{
  "metadata": {
    "generated_at": "2025-10-18T17:00:08.402592",
    "total_interventions": 82,
    "unique_interventions": 82,
    "unique_conditions": 39,
    "unique_papers": 41,
    "semantic_interventions": 82,
    "canonical_groups": 63,
    "positive_correlations": 0,
    "negative_correlations": 0,
    "intervention_categories": {},
    "condition_categories": {},
    "multi_category_stats": {},
    "multi_category_interventions": 0,
    "bayesian_scores_available": false,
    "total_relationships": 63,
    "high_scoring_interventions": 0,
    "medium_scoring_interventions": 0
  },
  "top_performers": {
    "interventions": [],
    "conditions": [
      {
        "name": "lupus nephritis, systemic lupus erythematosus",
        "condition_category": null,
        "count": 7,
        "intervention_count": 7,
        "paper_count": 2
      },
      {
        "name": "asthma",
        "condition_category": null,
        "count": 6,
        "intervention_count": 6,
        "paper_count": 1
      },
      {
        "name": "behavioral difficulties",
        "condition_category": null,
        "count": 6,
        "intervention_count": 6,
        "paper_count": 1
      },
      {
        "name": "irritable bowel syndrome",
        "condition_category": null,
        "count": 5,
        "intervention_count": 5,
        "paper_count": 1
      },
      {
        "name": "diabetic foot ulcers",
        "condition_category": null,
        "count": 4,
        "intervention_count": 4,
        "paper_count": 1
      },
      {
        "name": "obesity_severe_obesity",
        "condition_category": null,
        "count": 4,
        "intervention_count": 4,
        "paper_count": 3
      },
      {
        "name": "Helicobacter pylori infection",
        "condition_category": null,
        "count": 3,
        "intervention_count": 3,
        "paper_count": 1
      },
      {
        "name": "actinic keratoses",
        "condition_category": null,
        "count": 3,
        "intervention_count": 3,
        "paper_count": 1
      },
      {
        "name": "knee osteoarthritis",
        "condition_category": null,
        "count": 3,
        "intervention_count": 3,
        "paper_count": 1
      },
      {
        "name": "rotator cuff tear",
        "condition_category": null,
        "count": 3,
        "intervention_count": 3,
        "paper_count": 1
      }
    ]
  },
  "interventions": [
    {
      "id": 1,
      "intervention": {
        "name": "Xiao-Feng-San combined with auricular acupuncture",
        "canonical_name": "xiao_feng_san_with_auricular_acupuncture",
        "category": null,
        "categories": {
          "primary": [
            "traditional_chinese_medicine_combination"
          ]
        },
        "details": "{}",
        "delivery_method": "acupuncture",
        "hierarchy": {
          "layer_0_category": "traditional_chinese_medicine_combination",
          "layer_1_canonical": "xiao_feng_san_with_auricular_acupuncture",
          "layer_2_variant": "Xiao-Feng-San combined with auricular acupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "atopic dermatitis",
        "canonical_name": "atopic dermatitis",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "atopic dermatitis",
          "layer_2_variant": "atopic dermatitis",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulating immune response and reducing inflammation",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 156,
        "duration": "4 weeks",
        "population": "adults with non-severe AD and wind-dampness-heat pattern",
        "adverse_effects": "mild and transient",
        "cost_category": null,
        "study_focus": [
          "efficacy of Xiao-Feng-San combined with auricular acupuncture",
          "comparison with sham acupuncture"
        ],
        "measured_metrics": [
          "SCORAD index",
          "Dermatology Life Quality Index (DLQI)",
          "fexofenadine use",
          "serum total IgE",
          "adverse events"
        ],
        "findings": [
          "XFS plus AA group showed significantly greater reduction in SCORAD (MD -9.1; p < 0.0001)",
          "DLQI improved more in XFS plus AA group (MD -1.8; p = 0.0362)",
          "Fexofenadine use was lower in XFS plus AA group (not statistically significant)",
          "No significant differences in serum total IgE",
          "Adverse events were mild and transient"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Efficacy of herbal medicine Xiao-Feng-San combined with auricular acupuncture for atopic dermatitis: A randomized controlled trial.",
        "journal": "Integrative medicine research",
        "publication_date": "2026-06",
        "pubmed_id": "41104111",
        "doi": "10.1016/j.imr.2025.101256"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:18:18"
    },
    {
      "id": 2,
      "intervention": {
        "name": "topical ivermectin 1%",
        "canonical_name": "topical_ivermectin",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "topical_ivermectin",
          "layer_2_variant": "topical ivermectin 1%",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Demodex-associated skin conditions",
        "canonical_name": "Demodex-associated skin conditions",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "Demodex-associated skin conditions",
          "layer_2_variant": "Demodex-associated skin conditions",
          "layer_3_detail": null
        }
      },
      "mechanism": "antiparasitic and anti-inflammatory effects",
      "mechanism_canonical_names": [
        "Anti-inflammatory and antioxidant effects"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 180,
        "duration": "16 weeks (with 12-week follow-up)",
        "population": "participants with Demodex-related skin diseases (rosacea, blepharitis, demodicosis)",
        "adverse_effects": "mild, localized adverse events; no systemic side effects",
        "cost_category": null,
        "study_focus": [
          "efficacy of topical ivermectin in reducing Demodex mite density",
          "clinical outcomes in Demodex-related diseases"
        ],
        "measured_metrics": [
          "Demodex mite count/cm²",
          "Demodex-positive rate (≥5 D/cm²)",
          "adverse event incidence"
        ],
        "findings": [
          "mean reduction of 70.01 mites/cm² (p<0.001)",
          "80% decrease in Demodex-positive rates (p<0.001)",
          "effects sustained for 12 weeks post-treatment",
          "only mild, localized adverse events reported"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Efficacy of topical Ivermectin in controlling human",
        "journal": "Parasite epidemiology and control",
        "publication_date": "2025-11",
        "pubmed_id": "41103378",
        "doi": "10.1016/j.parepi.2025.e00461"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:27:37"
    },
    {
      "id": 3,
      "intervention": {
        "name": "Racz catheter technique",
        "canonical_name": "racz_catheter_technique",
        "category": null,
        "categories": {
          "primary": [
            "spinal_intervention"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "spinal_intervention",
          "layer_1_canonical": "racz_catheter_technique",
          "layer_2_variant": "Racz catheter technique",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "low back pain",
        "canonical_name": "low back pain",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "low back pain",
          "layer_2_variant": "low back pain",
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted drug delivery with mechanical adhesiolysis",
      "mechanism_canonical_names": [
        "targeted drug delivery with mechanical adhesiolysis"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "6 months",
        "population": "patients aged 18-65 with persistent lumbar pain, grade 1 spondylolisthesis, and facet osteoarthropathy",
        "adverse_effects": "no significant increase compared to conventional",
        "cost_category": null,
        "study_focus": [
          "comparison of Racz catheter technique vs conventional technique",
          "pain relief efficacy",
          "functional outcomes"
        ],
        "measured_metrics": [
          "Visual Analog Scale (VAS) scores",
          "Oswestry Low Back Disability Questionnaire (OSW) scores",
          "patient satisfaction levels"
        ],
        "findings": [
          "VAS and OSW scores significantly lower in Racz group at 2, 4, and 6 months (P < 0.05)",
          "patient satisfaction significantly higher in Racz group (P < 0.05)",
          "no significant differences in adverse events between groups"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Racz Catheter Technique Versus Conventional Technique in Lumbar Epidural Steroid Injection for Management of Low Back Pain: A Randomized Controlled Trial.",
        "journal": "Anesthesiology and pain medicine",
        "publication_date": "2025-10-31",
        "pubmed_id": "41103371",
        "doi": "10.5812/aapm-164983"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:29:37"
    },
    {
      "id": 4,
      "intervention": {
        "name": "conventional lumbar epidural steroid injection",
        "canonical_name": "lumbar_epidural_steroid_injection",
        "category": null,
        "categories": {
          "primary": [
            "epidural_injection"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "epidural_injection",
          "layer_1_canonical": "lumbar_epidural_steroid_injection",
          "layer_2_variant": "conventional lumbar epidural steroid injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "low back pain",
        "canonical_name": "low back pain",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "low back pain",
          "layer_2_variant": "low back pain",
          "layer_3_detail": null
        }
      },
      "mechanism": "standard epidural steroid administration",
      "mechanism_canonical_names": [
        "epidural steroid administration for inflammation reduction"
      ],
      "correlation": {
        "type": "no_effect",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "6 months",
        "population": "patients aged 18-65 with persistent lumbar pain, grade 1 spondylolisthesis, and facet osteoarthropathy",
        "adverse_effects": "no significant increase compared to Racz",
        "cost_category": null,
        "study_focus": [
          "comparison of Racz catheter technique vs conventional technique",
          "pain relief efficacy",
          "functional outcomes"
        ],
        "measured_metrics": [
          "Visual Analog Scale (VAS) scores",
          "Oswestry Low Back Disability Questionnaire (OSW) scores",
          "patient satisfaction levels"
        ],
        "findings": [
          "VAS and OSW scores significantly lower in Racz group at 2, 4, and 6 months (P < 0.05)",
          "patient satisfaction significantly higher in Racz group (P < 0.05)",
          "no significant differences in adverse events between groups"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Racz Catheter Technique Versus Conventional Technique in Lumbar Epidural Steroid Injection for Management of Low Back Pain: A Randomized Controlled Trial.",
        "journal": "Anesthesiology and pain medicine",
        "publication_date": "2025-10-31",
        "pubmed_id": "41103371",
        "doi": "10.5812/aapm-164983"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:29:37"
    },
    {
      "id": 5,
      "intervention": {
        "name": "tegoprazan (half-dose)",
        "canonical_name": "tegoprazan",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "tegoprazan",
          "layer_2_variant": "tegoprazan (half-dose)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD)",
        "canonical_name": "gastroesophageal reflux disease (GERD)",
        "category": null,
        "categories": {
          "primary": [
            "digestive"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "digestive",
          "layer_1_canonical": "gastroesophageal reflux disease (GERD)",
          "layer_2_variant": "gastroesophageal reflux disease (GERD)",
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces serum gastrin levels and incidence of hypergastrinemia",
      "mechanism_canonical_names": [
        "Regulation of serum gastrin levels"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": null,
        "sample_size": 346,
        "duration": "24 weeks",
        "population": "patients with GERD undergoing treatment",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effect of tegoprazan on serum gastrin levels",
          "comparison of hypergastrinemia development between tegoprazan and lansoprazole"
        ],
        "measured_metrics": [
          "serum gastrin levels",
          "proportion of hypergastrinemia (>115 pg/mL)"
        ],
        "findings": [
          "baseline gastrin levels were similar between groups (P = 0.335)",
          "tegoprazan group had significantly lower gastrin levels at weeks 16 (P = 0.001) and 24 (P = 0.001) compared to lansoprazole",
          "tegoprazan group had lower incidence of hypergastrinemia compared to lansoprazole"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effect of Tegoprazan on Serum Gastrin Levels and the Development of Hypergastrinemia in the Maintenance Treatment for Gastroesophageal Reflux Disease: Comparison to Lansoprazole.",
        "journal": "Journal of neurogastroenterology and motility",
        "publication_date": "2025-10-30",
        "pubmed_id": "41077753",
        "doi": "10.5056/jnm25104"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:37:01"
    },
    {
      "id": 6,
      "intervention": {
        "name": "lansoprazole (standard dose)",
        "canonical_name": "lansoprazole",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "lansoprazole",
          "layer_2_variant": "lansoprazole (standard dose)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "gastroesophageal reflux disease (GERD)",
        "canonical_name": "gastroesophageal reflux disease (GERD)",
        "category": null,
        "categories": {
          "primary": [
            "digestive"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "digestive",
          "layer_1_canonical": "gastroesophageal reflux disease (GERD)",
          "layer_2_variant": "gastroesophageal reflux disease (GERD)",
          "layer_3_detail": null
        }
      },
      "mechanism": "associated with higher serum gastrin levels and increased incidence of hypergastrinemia",
      "mechanism_canonical_names": [
        "Regulation of serum gastrin levels"
      ],
      "correlation": {
        "type": "worsens",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": null,
        "sample_size": 346,
        "duration": "24 weeks",
        "population": "patients with GERD undergoing treatment",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effect of tegoprazan on serum gastrin levels",
          "comparison of hypergastrinemia development between tegoprazan and lansoprazole"
        ],
        "measured_metrics": [
          "serum gastrin levels",
          "proportion of hypergastrinemia (>115 pg/mL)"
        ],
        "findings": [
          "baseline gastrin levels were similar between groups (P = 0.335)",
          "tegoprazan group had significantly lower gastrin levels at weeks 16 (P = 0.001) and 24 (P = 0.001) compared to lansoprazole",
          "tegoprazan group had lower incidence of hypergastrinemia compared to lansoprazole"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effect of Tegoprazan on Serum Gastrin Levels and the Development of Hypergastrinemia in the Maintenance Treatment for Gastroesophageal Reflux Disease: Comparison to Lansoprazole.",
        "journal": "Journal of neurogastroenterology and motility",
        "publication_date": "2025-10-30",
        "pubmed_id": "41077753",
        "doi": "10.5056/jnm25104"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:37:01"
    },
    {
      "id": 7,
      "intervention": {
        "name": "reframing intervention",
        "canonical_name": "reframing_intervention",
        "category": null,
        "categories": {
          "primary": [
            "cognitive_reframing"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "cognitive_reframing",
          "layer_1_canonical": "reframing_intervention",
          "layer_2_variant": "reframing intervention",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "multiple sclerosis",
        "canonical_name": "multiple sclerosis",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "multiple sclerosis",
          "layer_2_variant": "multiple sclerosis",
          "layer_3_detail": null
        }
      },
      "mechanism": "cognitive restructuring of exercise-related thinking patterns",
      "mechanism_canonical_names": [
        "Cognitive restructuring of exercise-related thinking patterns"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "mixed-method single-arm study",
        "sample_size": 22,
        "duration": "4 weeks",
        "population": "individuals with multiple sclerosis",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "physical activity behavior change",
          "cognitive bias modification"
        ],
        "measured_metrics": [
          "cognitive error scores",
          "light physical activity levels",
          "moderate-vigorous physical activity levels"
        ],
        "findings": [
          "cognitive errors decreased from 5.32 (pre) to 4.52 (1-week post, p=0.013)",
          "light PA increased from 2.26 (pre) to 3.14 (1-week post, p=0.029)",
          "moderate-vigorous PA increased from 2.76 (pre) to 5.76 (4-weeks post, p<0.01)",
          "PA improvements sustained at 4-week follow-up"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Reframing physical activity barriers in individuals with multiple sclerosis: a proof-of-concept study.",
        "journal": "Disability and rehabilitation",
        "publication_date": "2025-10-16",
        "pubmed_id": "41103050",
        "doi": "10.1080/09638288.2025.2572361"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:49:14"
    },
    {
      "id": 8,
      "intervention": {
        "name": "pharmacist-led CKD screening and education",
        "canonical_name": "ckd_screening_education",
        "category": null,
        "categories": {
          "primary": [
            "health_education"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "health_education",
          "layer_1_canonical": "ckd_screening_education",
          "layer_2_variant": "pharmacist-led CKD screening and education",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic kidney disease",
        "canonical_name": "chronic kidney disease",
        "category": null,
        "categories": {
          "primary": [
            "renal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "renal",
          "layer_1_canonical": "chronic kidney disease",
          "layer_2_variant": "chronic kidney disease",
          "layer_3_detail": null
        }
      },
      "mechanism": "increasing public awareness and early detection",
      "mechanism_canonical_names": [
        "health education and early detection"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": 9,
        "duration": null,
        "population": "patients in community pharmacies and general practitioners",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "CKD detection",
          "CKD management",
          "pharmacist-led interventions"
        ],
        "measured_metrics": [
          "early detection rates",
          "patient knowledge of CKD",
          "collaboration with general practitioners",
          "public awareness of CKD"
        ],
        "findings": [
          "pharmacist-led interventions improve early CKD detection",
          "enhanced collaboration with GPs through coordinated care",
          "increased public understanding of CKD risk factors",
          "facilitated earlier treatment initiation",
          "contributed to better long-term patient outcomes"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Enhancing chronic kidney disease screening through community pharmacists: a systematic review of pharmacist-led strategies.",
        "journal": "Polish archives of internal medicine",
        "publication_date": "2025-10-16",
        "pubmed_id": "41099719",
        "doi": "10.20452/pamw.17136"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 13:54:11"
    },
    {
      "id": 9,
      "intervention": {
        "name": "acupuncture at HT-7 (Shenmen) and GV-20 (Baihui)",
        "canonical_name": "acupuncture_at_ht7_and_gv20",
        "category": null,
        "categories": {
          "primary": [
            "acupuncture"
          ]
        },
        "details": "{}",
        "delivery_method": "acupuncture",
        "hierarchy": {
          "layer_0_category": "acupuncture",
          "layer_1_canonical": "acupuncture_at_ht7_and_gv20",
          "layer_2_variant": "acupuncture at HT-7 (Shenmen) and GV-20 (Baihui)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "generalized anxiety disorder",
        "canonical_name": "generalized anxiety disorder",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "generalized anxiety disorder",
          "layer_2_variant": "generalized anxiety disorder",
          "layer_3_detail": null
        }
      },
      "mechanism": "neural pathway modulation to reduce anxiety",
      "mechanism_canonical_names": [
        "neural pathway modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 60,
        "duration": "10 days",
        "population": "patients aged 20-55 with generalized anxiety disorder",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effect of acupuncture on anxiety levels",
          "effect on cardiovascular function"
        ],
        "measured_metrics": [
          "Hamilton Anxiety Rating Scale (HAM-A) score",
          "systolic blood pressure",
          "diastolic blood pressure",
          "pulse rate"
        ],
        "findings": [
          "significant reduction in anxiety levels (P < .001) in study group",
          "no significant changes in systolic BP (P = .686), diastolic BP (P = .998), or pulse rate (P = .925)"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Effect of Acupuncture at HT-7 (Shenmen) and GV-20 (Baihui) on Anxiety and Cardiovascular Functions in Generalized Anxiety Disorder: A Randomized Controlled Trial.",
        "journal": "International journal of psychiatry in medicine",
        "publication_date": "2025-10-16",
        "pubmed_id": "41101756",
        "doi": "10.1177/00912174251391031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:03:31"
    },
    {
      "id": 10,
      "intervention": {
        "name": "oral ketamine",
        "canonical_name": "ketamine",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "ketamine",
          "layer_2_variant": "oral ketamine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "major depressive disorder",
        "canonical_name": "depressive and anxiety disorders, major depressive disorder",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "depressive and anxiety disorders, major depressive disorder",
          "layer_2_variant": "major depressive disorder",
          "layer_3_detail": null
        }
      },
      "mechanism": "NMDA receptor antagonism leading to rapid antidepressant effects",
      "mechanism_canonical_names": [
        "NMDA receptor antagonism"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial and meta-analysis",
        "sample_size": 45,
        "duration": "two weeks (trial) and cumulative data (meta-analysis)",
        "population": null,
        "adverse_effects": "well-tolerated with no serious adverse events",
        "cost_category": null,
        "study_focus": [
          "efficacy of oral ketamine in treating depression",
          "comparison with midazolam as an active comparator",
          "antidepressant efficacy in meta-analysis"
        ],
        "measured_metrics": [
          "MADRS score reduction after one week",
          "response rates (NNT = 4.6 for ketamine)",
          "remission rates (NNT = 9.16 in meta-analysis)",
          "adverse event reporting (no serious events)"
        ],
        "findings": [
          "response rates favored ketamine with NNT = 4.6 at one week (95% CI: [2.4, 62.6])",
          "meta-analysis of 592 patients showed NNT = 4.89 for response and NNT = 9.16 for remission",
          "treatment was well-tolerated with no serious adverse events reported"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Oral ketamine for the treatment of major depressive and bipolar disorder, a randomized controlled trial and meta-analysis.",
        "journal": "Journal of affective disorders",
        "publication_date": "2025-10-14",
        "pubmed_id": "41101490",
        "doi": "10.1016/j.jad.2025.120466"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:30:47"
    },
    {
      "id": 11,
      "intervention": {
        "name": "prenatal iron-folic acid",
        "canonical_name": "prenatal_iron_folic_acid",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "prenatal_iron_folic_acid",
          "layer_2_variant": "prenatal iron-folic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral difficulties",
        "canonical_name": "behavioral difficulties",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "behavioral difficulties",
          "layer_2_variant": "behavioral difficulties",
          "layer_3_detail": null
        }
      },
      "mechanism": "nutrient support for neurodevelopment",
      "mechanism_canonical_names": [
        "nutrient support for neurodevelopment"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "cohort study",
        "sample_size": 1255,
        "duration": "cohort follow-up of children aged 7-9 years",
        "population": "school-aged children (7-9 years) in rural Nepal, offspring of participants in prenatal and preschool randomized trials",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": "impact of prenatal and preschool micronutrient supplementation on ADHD-related behaviors in school-aged children",
        "measured_metrics": [
          "parent-reported hyperactivity/oppositional behavior scores",
          "parent-reported inattention scores",
          "teacher-reported hyperactivity scores",
          "teacher-reported inattention scores"
        ],
        "findings": [
          "Prenatal iron-folic acid reduced oppositionality/hyperactivity and inattention scores (parent ratings)",
          "Prenatal iron-folic acid with zinc reversed the positive effect of iron-folic acid alone",
          "Prenatal multiple micronutrients reduced oppositionality/hyperactivity (parent and teacher ratings)",
          "Preschool iron-folic acid, zinc, or iron-folic acid+zinc reduced parent-reported inattention",
          "Preschool iron-folic acid or iron-folic acid+zinc reduced teacher-reported hyperactivity"
        ],
        "study_location": "Nepal",
        "publisher": null
      },
      "paper": {
        "title": "Prenatal and preschool micronutrient supplementation and behavioral outcomes in school aged children in Nepal - a cohort study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-13",
        "pubmed_id": "41092983",
        "doi": "10.1016/j.ajcnut.2025.10.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:41:53"
    },
    {
      "id": 12,
      "intervention": {
        "name": "prenatal iron-folic acid + zinc",
        "canonical_name": "prenatal_iron_folic_acid",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "prenatal_iron_folic_acid",
          "layer_2_variant": "prenatal iron-folic acid + zinc",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral difficulties",
        "canonical_name": "behavioral difficulties",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "behavioral difficulties",
          "layer_2_variant": "behavioral difficulties",
          "layer_3_detail": null
        }
      },
      "mechanism": "nutrient support for neurodevelopment",
      "mechanism_canonical_names": [
        "nutrient support for neurodevelopment"
      ],
      "correlation": {
        "type": "no_effect",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "cohort study",
        "sample_size": 1255,
        "duration": "cohort follow-up of children aged 7-9 years",
        "population": "school-aged children (7-9 years) in rural Nepal, offspring of participants in prenatal and preschool randomized trials",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": "impact of prenatal and preschool micronutrient supplementation on ADHD-related behaviors in school-aged children",
        "measured_metrics": [
          "parent-reported hyperactivity/oppositional behavior scores",
          "parent-reported inattention scores",
          "teacher-reported hyperactivity scores",
          "teacher-reported inattention scores"
        ],
        "findings": [
          "Prenatal iron-folic acid reduced oppositionality/hyperactivity and inattention scores (parent ratings)",
          "Prenatal iron-folic acid with zinc reversed the positive effect of iron-folic acid alone",
          "Prenatal multiple micronutrients reduced oppositionality/hyperactivity (parent and teacher ratings)",
          "Preschool iron-folic acid, zinc, or iron-folic acid+zinc reduced parent-reported inattention",
          "Preschool iron-folic acid or iron-folic acid+zinc reduced teacher-reported hyperactivity"
        ],
        "study_location": "Nepal",
        "publisher": null
      },
      "paper": {
        "title": "Prenatal and preschool micronutrient supplementation and behavioral outcomes in school aged children in Nepal - a cohort study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-13",
        "pubmed_id": "41092983",
        "doi": "10.1016/j.ajcnut.2025.10.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:41:53"
    },
    {
      "id": 13,
      "intervention": {
        "name": "prenatal multiple micronutrients",
        "canonical_name": "prenatal_iron_folic_acid",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "prenatal_iron_folic_acid",
          "layer_2_variant": "prenatal multiple micronutrients",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral difficulties",
        "canonical_name": "behavioral difficulties",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "behavioral difficulties",
          "layer_2_variant": "behavioral difficulties",
          "layer_3_detail": null
        }
      },
      "mechanism": "nutrient support for neurodevelopment",
      "mechanism_canonical_names": [
        "nutrient support for neurodevelopment"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "cohort study",
        "sample_size": 1255,
        "duration": "cohort follow-up of children aged 7-9 years",
        "population": "school-aged children (7-9 years) in rural Nepal, offspring of participants in prenatal and preschool randomized trials",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": "impact of prenatal and preschool micronutrient supplementation on ADHD-related behaviors in school-aged children",
        "measured_metrics": [
          "parent-reported hyperactivity/oppositional behavior scores",
          "parent-reported inattention scores",
          "teacher-reported hyperactivity scores",
          "teacher-reported inattention scores"
        ],
        "findings": [
          "Prenatal iron-folic acid reduced oppositionality/hyperactivity and inattention scores (parent ratings)",
          "Prenatal iron-folic acid with zinc reversed the positive effect of iron-folic acid alone",
          "Prenatal multiple micronutrients reduced oppositionality/hyperactivity (parent and teacher ratings)",
          "Preschool iron-folic acid, zinc, or iron-folic acid+zinc reduced parent-reported inattention",
          "Preschool iron-folic acid or iron-folic acid+zinc reduced teacher-reported hyperactivity"
        ],
        "study_location": "Nepal",
        "publisher": null
      },
      "paper": {
        "title": "Prenatal and preschool micronutrient supplementation and behavioral outcomes in school aged children in Nepal - a cohort study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-13",
        "pubmed_id": "41092983",
        "doi": "10.1016/j.ajcnut.2025.10.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:41:53"
    },
    {
      "id": 14,
      "intervention": {
        "name": "preschool iron-folic acid",
        "canonical_name": "preschool_iron_folic_acid",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "preschool_iron_folic_acid",
          "layer_2_variant": "preschool iron-folic acid",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral difficulties",
        "canonical_name": "behavioral difficulties",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "behavioral difficulties",
          "layer_2_variant": "behavioral difficulties",
          "layer_3_detail": null
        }
      },
      "mechanism": "nutrient support for neurodevelopment",
      "mechanism_canonical_names": [
        "nutrient support for neurodevelopment"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "cohort study",
        "sample_size": 1255,
        "duration": "cohort follow-up of children aged 7-9 years",
        "population": "school-aged children (7-9 years) in rural Nepal, offspring of participants in prenatal and preschool randomized trials",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": "impact of prenatal and preschool micronutrient supplementation on ADHD-related behaviors in school-aged children",
        "measured_metrics": [
          "parent-reported hyperactivity/oppositional behavior scores",
          "parent-reported inattention scores",
          "teacher-reported hyperactivity scores",
          "teacher-reported inattention scores"
        ],
        "findings": [
          "Prenatal iron-folic acid reduced oppositionality/hyperactivity and inattention scores (parent ratings)",
          "Prenatal iron-folic acid with zinc reversed the positive effect of iron-folic acid alone",
          "Prenatal multiple micronutrients reduced oppositionality/hyperactivity (parent and teacher ratings)",
          "Preschool iron-folic acid, zinc, or iron-folic acid+zinc reduced parent-reported inattention",
          "Preschool iron-folic acid or iron-folic acid+zinc reduced teacher-reported hyperactivity"
        ],
        "study_location": "Nepal",
        "publisher": null
      },
      "paper": {
        "title": "Prenatal and preschool micronutrient supplementation and behavioral outcomes in school aged children in Nepal - a cohort study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-13",
        "pubmed_id": "41092983",
        "doi": "10.1016/j.ajcnut.2025.10.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:41:53"
    },
    {
      "id": 15,
      "intervention": {
        "name": "preschool zinc",
        "canonical_name": "preschool_iron_folic_acid",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "preschool_iron_folic_acid",
          "layer_2_variant": "preschool zinc",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral difficulties",
        "canonical_name": "behavioral difficulties",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "behavioral difficulties",
          "layer_2_variant": "behavioral difficulties",
          "layer_3_detail": null
        }
      },
      "mechanism": "nutrient support for neurodevelopment",
      "mechanism_canonical_names": [
        "nutrient support for neurodevelopment"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "cohort study",
        "sample_size": 1255,
        "duration": "cohort follow-up of children aged 7-9 years",
        "population": "school-aged children (7-9 years) in rural Nepal, offspring of participants in prenatal and preschool randomized trials",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": "impact of prenatal and preschool micronutrient supplementation on ADHD-related behaviors in school-aged children",
        "measured_metrics": [
          "parent-reported hyperactivity/oppositional behavior scores",
          "parent-reported inattention scores",
          "teacher-reported hyperactivity scores",
          "teacher-reported inattention scores"
        ],
        "findings": [
          "Prenatal iron-folic acid reduced oppositionality/hyperactivity and inattention scores (parent ratings)",
          "Prenatal iron-folic acid with zinc reversed the positive effect of iron-folic acid alone",
          "Prenatal multiple micronutrients reduced oppositionality/hyperactivity (parent and teacher ratings)",
          "Preschool iron-folic acid, zinc, or iron-folic acid+zinc reduced parent-reported inattention",
          "Preschool iron-folic acid or iron-folic acid+zinc reduced teacher-reported hyperactivity"
        ],
        "study_location": "Nepal",
        "publisher": null
      },
      "paper": {
        "title": "Prenatal and preschool micronutrient supplementation and behavioral outcomes in school aged children in Nepal - a cohort study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-13",
        "pubmed_id": "41092983",
        "doi": "10.1016/j.ajcnut.2025.10.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:41:53"
    },
    {
      "id": 16,
      "intervention": {
        "name": "preschool iron-folic acid + zinc",
        "canonical_name": "preschool_iron_folic_acid",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "preschool_iron_folic_acid",
          "layer_2_variant": "preschool iron-folic acid + zinc",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "behavioral difficulties",
        "canonical_name": "behavioral difficulties",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "behavioral difficulties",
          "layer_2_variant": "behavioral difficulties",
          "layer_3_detail": null
        }
      },
      "mechanism": "nutrient support for neurodevelopment",
      "mechanism_canonical_names": [
        "nutrient support for neurodevelopment"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "cohort study",
        "sample_size": 1255,
        "duration": "cohort follow-up of children aged 7-9 years",
        "population": "school-aged children (7-9 years) in rural Nepal, offspring of participants in prenatal and preschool randomized trials",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": "impact of prenatal and preschool micronutrient supplementation on ADHD-related behaviors in school-aged children",
        "measured_metrics": [
          "parent-reported hyperactivity/oppositional behavior scores",
          "parent-reported inattention scores",
          "teacher-reported hyperactivity scores",
          "teacher-reported inattention scores"
        ],
        "findings": [
          "Prenatal iron-folic acid reduced oppositionality/hyperactivity and inattention scores (parent ratings)",
          "Prenatal iron-folic acid with zinc reversed the positive effect of iron-folic acid alone",
          "Prenatal multiple micronutrients reduced oppositionality/hyperactivity (parent and teacher ratings)",
          "Preschool iron-folic acid, zinc, or iron-folic acid+zinc reduced parent-reported inattention",
          "Preschool iron-folic acid or iron-folic acid+zinc reduced teacher-reported hyperactivity"
        ],
        "study_location": "Nepal",
        "publisher": null
      },
      "paper": {
        "title": "Prenatal and preschool micronutrient supplementation and behavioral outcomes in school aged children in Nepal - a cohort study.",
        "journal": "The American journal of clinical nutrition",
        "publication_date": "2025-10-13",
        "pubmed_id": "41092983",
        "doi": "10.1016/j.ajcnut.2025.10.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:41:53"
    },
    {
      "id": 17,
      "intervention": {
        "name": "recumbent isometric yoga",
        "canonical_name": "recumbent_isometric_yoga",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "recumbent_isometric_yoga",
          "layer_2_variant": "recumbent isometric yoga",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)",
        "canonical_name": "myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)",
        "category": null,
        "categories": {
          "primary": [
            "multisystem"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "multisystem",
          "layer_1_canonical": "myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)",
          "layer_2_variant": "myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)",
          "layer_3_detail": null
        }
      },
      "mechanism": "Improves physical symptoms and brain fog, enhances awareness of activity limits, and promotes behavioral changes to manage post-exertional malaise",
      "mechanism_canonical_names": [
        "Post-exertional malaise management"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 48,
        "duration": "12 weeks",
        "population": "Adults with ME/CFS who did not improve after ≥3 months of conventional therapy (7 male, 41 female; age 20–70 years), including those with comorbid FM",
        "adverse_effects": "No serious adverse effects reported",
        "cost_category": null,
        "study_focus": [
          "effect of recumbent isometric yoga on daily functioning",
          "fatigue reduction in ME/CFS patients"
        ],
        "measured_metrics": [
          "Performance Status (PS) scores",
          "Chalder Fatigue Scale (FS) scores",
          "Profile of Mood States (POMS) scores"
        ],
        "findings": [
          "PS scores significantly lower in the yoga group (P < 0.001) compared to control, indicating improved functioning",
          "Chalder FS scores decreased more in the yoga group (P < 0.01) than control",
          "Subgroup analysis showed significant reduction in Chalder FS scores for severe ME/CFS and comorbid fibromyalgia (FM) patients (P < 0.001 and P < 0.01, respectively)",
          "No serious adverse effects reported; patients noted improvements in physical symptoms, brain fog, and behavioral changes"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Effects of recumbent isometric yoga on the daily functioning level of patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, controlled trial.",
        "journal": "BioPsychoSocial medicine",
        "publication_date": "2025-10-10",
        "pubmed_id": "41074089",
        "doi": "10.1186/s13030-025-00339-7"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:52:53"
    },
    {
      "id": 18,
      "intervention": {
        "name": "surgical embolectomy",
        "canonical_name": "surgical_embolectomy",
        "category": null,
        "categories": {
          "primary": [
            "surgical_procedure"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgical_procedure",
          "layer_1_canonical": "surgical_embolectomy",
          "layer_2_variant": "surgical embolectomy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "pulmonary embolism",
        "canonical_name": "pulmonary embolism",
        "category": null,
        "categories": {
          "primary": [
            "cardiac"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "cardiac",
          "layer_1_canonical": "pulmonary embolism",
          "layer_2_variant": "pulmonary embolism",
          "layer_3_detail": null
        }
      },
      "mechanism": "direct mechanical clot removal",
      "mechanism_canonical_names": [
        "Direct mechanical clot removal"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 1598,
        "duration": "variable (3595.5 patient years)",
        "population": "intermediate- and high-risk PE patients",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "comparison of reperfusion strategies",
          "mortality outcomes in PE treatment"
        ],
        "measured_metrics": [
          "in-hospital mortality",
          "major bleeding incidence",
          "right ventricular function"
        ],
        "findings": [
          "CDI/SE showed 34-37% lower mortality vs ST (OR 0.34-0.37)",
          "CDI reduced RV dysfunction (OR 0.28)",
          "CDI trended toward fewer bleeding complications",
          "ST had highest mortality (P-score 0.0008)"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Has systemic thrombolysis run its course? A systematic review and network meta-analysis of patients with intermediate- and high-risk pulmonary embolism.",
        "journal": "Thrombosis research",
        "publication_date": "2025-10-09",
        "pubmed_id": "41076852",
        "doi": "10.1016/j.thromres.2025.109503"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:55:06"
    },
    {
      "id": 19,
      "intervention": {
        "name": "photolyase",
        "canonical_name": "photolyase",
        "category": null,
        "categories": {
          "primary": [
            "biological_agent"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "biological_agent",
          "layer_1_canonical": "photolyase",
          "layer_2_variant": "photolyase",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratoses",
        "canonical_name": "actinic keratoses",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "actinic keratoses",
          "layer_2_variant": "actinic keratoses",
          "layer_3_detail": null
        }
      },
      "mechanism": "direct repair of UV-induced DNA damage",
      "mechanism_canonical_names": [
        "Direct repair of UV-induced DNA damage"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized clinical trials and quasi-experimental trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "prevention and treatment of actinic keratoses and keratinocyte skin cancer using DNA repair enzymes"
        ],
        "measured_metrics": [
          "DNA damage levels",
          "incidence of skin cancer"
        ],
        "findings": [
          "DNA repair enzymes reduce DNA damage",
          "combination with traditional photoprotectors enhances efficacy",
          "heterogeneity limits definitive conclusions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "[[Translated article]]DNA Repair Enzymes for Actinic Keratoses and Keratinocyte Cancer: A Systematic Review of Treatment and Prevention Utility.",
        "journal": "Actas dermo-sifiliograficas",
        "publication_date": "2025-10-07",
        "pubmed_id": "41067614",
        "doi": "10.1016/j.ad.2025.10.001"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:57:50"
    },
    {
      "id": 20,
      "intervention": {
        "name": "endonuclease",
        "canonical_name": "endonuclease",
        "category": null,
        "categories": {
          "primary": [
            "gene_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "gene_therapy",
          "layer_1_canonical": "endonuclease",
          "layer_2_variant": "endonuclease",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratoses",
        "canonical_name": "actinic keratoses",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "actinic keratoses",
          "layer_2_variant": "actinic keratoses",
          "layer_3_detail": null
        }
      },
      "mechanism": "removal of UV-damaged DNA segments",
      "mechanism_canonical_names": [
        "Direct repair of UV-induced DNA damage"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized clinical trials and quasi-experimental trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "prevention and treatment of actinic keratoses and keratinocyte skin cancer using DNA repair enzymes"
        ],
        "measured_metrics": [
          "DNA damage levels",
          "incidence of skin cancer"
        ],
        "findings": [
          "DNA repair enzymes reduce DNA damage",
          "combination with traditional photoprotectors enhances efficacy",
          "heterogeneity limits definitive conclusions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "[[Translated article]]DNA Repair Enzymes for Actinic Keratoses and Keratinocyte Cancer: A Systematic Review of Treatment and Prevention Utility.",
        "journal": "Actas dermo-sifiliograficas",
        "publication_date": "2025-10-07",
        "pubmed_id": "41067614",
        "doi": "10.1016/j.ad.2025.10.001"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:57:50"
    },
    {
      "id": 21,
      "intervention": {
        "name": "combination of DNA repair enzymes",
        "canonical_name": "dna_repair_enzymes_combination",
        "category": null,
        "categories": {
          "primary": [
            "dna_repair_supplement"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "dna_repair_supplement",
          "layer_1_canonical": "dna_repair_enzymes_combination",
          "layer_2_variant": "combination of DNA repair enzymes",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "actinic keratoses",
        "canonical_name": "actinic keratoses",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "actinic keratoses",
          "layer_2_variant": "actinic keratoses",
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic DNA repair enhancement",
      "mechanism_canonical_names": [
        "synergistic DNA repair enhancement"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized clinical trials and quasi-experimental trials",
        "sample_size": null,
        "duration": null,
        "population": null,
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "prevention and treatment of actinic keratoses and keratinocyte skin cancer using DNA repair enzymes"
        ],
        "measured_metrics": [
          "DNA damage levels",
          "incidence of skin cancer"
        ],
        "findings": [
          "DNA repair enzymes reduce DNA damage",
          "combination with traditional photoprotectors enhances efficacy",
          "heterogeneity limits definitive conclusions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "[[Translated article]]DNA Repair Enzymes for Actinic Keratoses and Keratinocyte Cancer: A Systematic Review of Treatment and Prevention Utility.",
        "journal": "Actas dermo-sifiliograficas",
        "publication_date": "2025-10-07",
        "pubmed_id": "41067614",
        "doi": "10.1016/j.ad.2025.10.001"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 14:57:50"
    },
    {
      "id": 22,
      "intervention": {
        "name": "anifrolumab",
        "canonical_name": "anifrolumab",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "intravenous",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "anifrolumab",
          "layer_2_variant": "anifrolumab",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "lupus nephritis",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "lupus nephritis",
          "layer_3_detail": null
        }
      },
      "mechanism": "type I interferon receptor blockade",
      "mechanism_canonical_names": [
        "type I interferon receptor blockade"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "phase 2 trial",
        "sample_size": 128,
        "duration": "52 weeks",
        "population": "patients with lupus nephritis receiving standard therapy plus anifrolumab or placebo",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "metabolomic changes in response to anifrolumab",
          "association between metabolites and disease activity"
        ],
        "measured_metrics": [
          "serum indoxyl sulfate levels",
          "urine uracil levels",
          "cytosine concentrations",
          "markers of vascular dysfunction",
          "inflammatory markers"
        ],
        "findings": [
          "anifrolumab modulated indoxyl sulfate and cytosine in serum",
          "uracil and cytosine levels in urine correlated with disease activity",
          "anifrolumab reduced vascular dysfunction and inflammation markers",
          "baseline urine uracil predicted response to anifrolumab at Week 52"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial.",
        "journal": "RMD open",
        "publication_date": "2025-10-05",
        "pubmed_id": "41052889",
        "doi": "10.1136/rmdopen-2025-005932"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:06:25"
    },
    {
      "id": 23,
      "intervention": {
        "name": "local heat application",
        "canonical_name": "local_heat_application",
        "category": null,
        "categories": {
          "primary": [
            "physical_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "physical_therapy",
          "layer_1_canonical": "local_heat_application",
          "layer_2_variant": "local heat application",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chemotherapy-induced peripheral neuropathy",
        "canonical_name": "chemotherapy-induced peripheral neuropathy",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "chemotherapy-induced peripheral neuropathy",
          "layer_2_variant": "chemotherapy-induced peripheral neuropathy",
          "layer_3_detail": null
        }
      },
      "mechanism": "improves blood flow and nerve function",
      "mechanism_canonical_names": [
        "vascular and neural enhancement"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 96,
        "duration": "during chemotherapy cycles",
        "population": "breast cancer patients with CIPN undergoing taxane-based chemotherapy",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effectiveness of heat vs cold application on CIPN symptoms",
          "non-pharmacological CIPN management"
        ],
        "measured_metrics": [
          "neuropathy evaluation tool scores",
          "symptom severity (toe numbness, finger discomfort, cold sensitivity, physical activity difficulty)"
        ],
        "findings": [
          "heat group showed significant symptom reduction (p<0.05)",
          "cold group had moderate sensory improvements",
          "control group experienced worsening symptoms over time"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The effect of local heat and cold application on the management of chemotherapy-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial.",
        "journal": "European journal of oncology nursing : the official journal of European Oncology Nursing Society",
        "publication_date": "2025-10-04",
        "pubmed_id": "41101215",
        "doi": "10.1016/j.ejon.2025.102998"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:08:09"
    },
    {
      "id": 24,
      "intervention": {
        "name": "local cold application",
        "canonical_name": "local_cold_application",
        "category": null,
        "categories": {
          "primary": [
            "physical_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "physical_therapy",
          "layer_1_canonical": "local_cold_application",
          "layer_2_variant": "local cold application",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chemotherapy-induced peripheral neuropathy",
        "canonical_name": "chemotherapy-induced peripheral neuropathy",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "chemotherapy-induced peripheral neuropathy",
          "layer_2_variant": "chemotherapy-induced peripheral neuropathy",
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces inflammation and pain",
      "mechanism_canonical_names": [
        "anti-inflammatory and tissue healing effects"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 96,
        "duration": "during chemotherapy cycles",
        "population": "breast cancer patients with CIPN undergoing taxane-based chemotherapy",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effectiveness of heat vs cold application on CIPN symptoms",
          "non-pharmacological CIPN management"
        ],
        "measured_metrics": [
          "neuropathy evaluation tool scores",
          "symptom severity (toe numbness, finger discomfort, cold sensitivity, physical activity difficulty)"
        ],
        "findings": [
          "heat group showed significant symptom reduction (p<0.05)",
          "cold group had moderate sensory improvements",
          "control group experienced worsening symptoms over time"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The effect of local heat and cold application on the management of chemotherapy-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial.",
        "journal": "European journal of oncology nursing : the official journal of European Oncology Nursing Society",
        "publication_date": "2025-10-04",
        "pubmed_id": "41101215",
        "doi": "10.1016/j.ejon.2025.102998"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:08:09"
    },
    {
      "id": 25,
      "intervention": {
        "name": "aerobic exercise",
        "canonical_name": "aerobic_exercise",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "aerobic_exercise",
          "layer_2_variant": "aerobic exercise",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "systemic lupus erythematosus",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced cardiovascular function and aerobic capacity",
      "mechanism_canonical_names": [
        "Enhanced cardiovascular and muscular function"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 619,
        "duration": "variable (6 weeks to 12 months)",
        "population": "adults with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "functional aerobic capacity improvement",
          "quality of life enhancement"
        ],
        "measured_metrics": [
          "functional aerobic capacity",
          "quality of life domains (physical health, vitality, fatigue)",
          "fatigue levels",
          "depression scores",
          "pain levels",
          "sleep quality",
          "insulin sensitivity",
          "self-care ability"
        ],
        "findings": [
          "supervised aerobic and combined interventions improved functional aerobic capacity",
          "quality of life benefits across physical health, vitality, and fatigue domains",
          "improvements in fatigue, depression, pain, sleep, insulin sensitivity, and self-care ability",
          "no evidence of increased disease activity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-10-04",
        "pubmed_id": "41096111",
        "doi": "10.3390/jcm14197031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:12:24"
    },
    {
      "id": 26,
      "intervention": {
        "name": "resistance training",
        "canonical_name": "combined_aerobic_and_resistance_training",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "combined_aerobic_and_resistance_training",
          "layer_2_variant": "resistance training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "systemic lupus erythematosus",
          "layer_3_detail": null
        }
      },
      "mechanism": "increased muscle strength and physical endurance",
      "mechanism_canonical_names": [
        "neuromuscular enhancement and endurance"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 619,
        "duration": "variable (6 weeks to 12 months)",
        "population": "adults with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "functional aerobic capacity improvement",
          "quality of life enhancement"
        ],
        "measured_metrics": [
          "functional aerobic capacity",
          "quality of life domains (physical health, vitality, fatigue)",
          "fatigue levels",
          "depression scores",
          "pain levels",
          "sleep quality",
          "insulin sensitivity",
          "self-care ability"
        ],
        "findings": [
          "supervised aerobic and combined interventions improved functional aerobic capacity",
          "quality of life benefits across physical health, vitality, and fatigue domains",
          "improvements in fatigue, depression, pain, sleep, insulin sensitivity, and self-care ability",
          "no evidence of increased disease activity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-10-04",
        "pubmed_id": "41096111",
        "doi": "10.3390/jcm14197031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:12:24"
    },
    {
      "id": 27,
      "intervention": {
        "name": "combined aerobic and resistance training",
        "canonical_name": "combined_aerobic_and_resistance_training",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "combined_aerobic_and_resistance_training",
          "layer_2_variant": "combined aerobic and resistance training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "systemic lupus erythematosus",
          "layer_3_detail": null
        }
      },
      "mechanism": "synergistic improvements in cardiovascular and muscular function",
      "mechanism_canonical_names": [
        "Enhanced cardiovascular and muscular function"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 619,
        "duration": "variable (6 weeks to 12 months)",
        "population": "adults with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "functional aerobic capacity improvement",
          "quality of life enhancement"
        ],
        "measured_metrics": [
          "functional aerobic capacity",
          "quality of life domains (physical health, vitality, fatigue)",
          "fatigue levels",
          "depression scores",
          "pain levels",
          "sleep quality",
          "insulin sensitivity",
          "self-care ability"
        ],
        "findings": [
          "supervised aerobic and combined interventions improved functional aerobic capacity",
          "quality of life benefits across physical health, vitality, and fatigue domains",
          "improvements in fatigue, depression, pain, sleep, insulin sensitivity, and self-care ability",
          "no evidence of increased disease activity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-10-04",
        "pubmed_id": "41096111",
        "doi": "10.3390/jcm14197031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:12:24"
    },
    {
      "id": 28,
      "intervention": {
        "name": "vibration training",
        "canonical_name": "vibration_training",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "vibration_training",
          "layer_2_variant": "vibration training",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "systemic lupus erythematosus",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced neuromuscular activation and balance",
      "mechanism_canonical_names": [
        "neuromuscular enhancement and endurance"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 619,
        "duration": "variable (6 weeks to 12 months)",
        "population": "adults with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "functional aerobic capacity improvement",
          "quality of life enhancement"
        ],
        "measured_metrics": [
          "functional aerobic capacity",
          "quality of life domains (physical health, vitality, fatigue)",
          "fatigue levels",
          "depression scores",
          "pain levels",
          "sleep quality",
          "insulin sensitivity",
          "self-care ability"
        ],
        "findings": [
          "supervised aerobic and combined interventions improved functional aerobic capacity",
          "quality of life benefits across physical health, vitality, and fatigue domains",
          "improvements in fatigue, depression, pain, sleep, insulin sensitivity, and self-care ability",
          "no evidence of increased disease activity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-10-04",
        "pubmed_id": "41096111",
        "doi": "10.3390/jcm14197031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:12:24"
    },
    {
      "id": 29,
      "intervention": {
        "name": "home-based exercise protocols",
        "canonical_name": "home_based_exercise_protocols",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "home_based_exercise_protocols",
          "layer_2_variant": "home-based exercise protocols",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "systemic lupus erythematosus",
          "layer_3_detail": null
        }
      },
      "mechanism": "self-directed physical activity and adherence",
      "mechanism_canonical_names": [
        "self-directed physical activity promotion"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 619,
        "duration": "variable (6 weeks to 12 months)",
        "population": "adults with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "functional aerobic capacity improvement",
          "quality of life enhancement"
        ],
        "measured_metrics": [
          "functional aerobic capacity",
          "quality of life domains (physical health, vitality, fatigue)",
          "fatigue levels",
          "depression scores",
          "pain levels",
          "sleep quality",
          "insulin sensitivity",
          "self-care ability"
        ],
        "findings": [
          "supervised aerobic and combined interventions improved functional aerobic capacity",
          "quality of life benefits across physical health, vitality, and fatigue domains",
          "improvements in fatigue, depression, pain, sleep, insulin sensitivity, and self-care ability",
          "no evidence of increased disease activity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-10-04",
        "pubmed_id": "41096111",
        "doi": "10.3390/jcm14197031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:12:24"
    },
    {
      "id": 30,
      "intervention": {
        "name": "counseling strategies",
        "canonical_name": "counseling_strategies",
        "category": null,
        "categories": {
          "primary": [
            "behavioral_intervention"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "behavioral_intervention",
          "layer_1_canonical": "counseling_strategies",
          "layer_2_variant": "counseling strategies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "systemic lupus erythematosus",
        "canonical_name": "lupus nephritis, systemic lupus erythematosus",
        "category": null,
        "categories": {
          "primary": [
            "autoimmune"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "autoimmune",
          "layer_1_canonical": "lupus nephritis, systemic lupus erythematosus",
          "layer_2_variant": "systemic lupus erythematosus",
          "layer_3_detail": null
        }
      },
      "mechanism": "behavioral modification and motivation enhancement",
      "mechanism_canonical_names": [
        "Behavioral modification and motivation enhancement"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review of randomized controlled trials",
        "sample_size": 619,
        "duration": "variable (6 weeks to 12 months)",
        "population": "adults with systemic lupus erythematosus",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "functional aerobic capacity improvement",
          "quality of life enhancement"
        ],
        "measured_metrics": [
          "functional aerobic capacity",
          "quality of life domains (physical health, vitality, fatigue)",
          "fatigue levels",
          "depression scores",
          "pain levels",
          "sleep quality",
          "insulin sensitivity",
          "self-care ability"
        ],
        "findings": [
          "supervised aerobic and combined interventions improved functional aerobic capacity",
          "quality of life benefits across physical health, vitality, and fatigue domains",
          "improvements in fatigue, depression, pain, sleep, insulin sensitivity, and self-care ability",
          "no evidence of increased disease activity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "The Effects of Exercise Training on Functional Aerobic Capacity and Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review of Randomized Controlled Trials.",
        "journal": "Journal of clinical medicine",
        "publication_date": "2025-10-04",
        "pubmed_id": "41096111",
        "doi": "10.3390/jcm14197031"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:12:24"
    },
    {
      "id": 31,
      "intervention": {
        "name": "prebiotic-containing gel cream",
        "canonical_name": "prebiotic_gel_cream",
        "category": null,
        "categories": {
          "primary": [
            "topical_supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "topical_supplement",
          "layer_1_canonical": "prebiotic_gel_cream",
          "layer_2_variant": "prebiotic-containing gel cream",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "acne vulgaris",
        "canonical_name": "acne vulgaris",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "acne vulgaris",
          "layer_2_variant": "acne vulgaris",
          "layer_3_detail": null
        }
      },
      "mechanism": "promotes beneficial shifts in skin microbiome",
      "mechanism_canonical_names": [
        "skin microbiome modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "open-label, prospective study",
        "sample_size": 30,
        "duration": "7 weeks",
        "population": "individuals with non-cystic acne-prone skin",
        "adverse_effects": "none reported",
        "cost_category": null,
        "study_focus": [
          "prebiotic gel cream efficacy on acne management",
          "effects on skin microbiome"
        ],
        "measured_metrics": [
          "C. acnes abundance",
          "functional gene analysis for skin barrier and inflammation-related genes",
          "acne lesion counts"
        ],
        "findings": [
          "non-inflammatory lesions reduced by 36.0%",
          "inflammatory lesions reduced by 34.5%",
          "total lesions reduced by 35.9%",
          "12.5 log2 fold increase in healthy C. acnes strain",
          "no adverse effects reported"
        ],
        "study_location": "Sacramento region",
        "publisher": null
      },
      "paper": {
        "title": "Open-Label, Prospective Study of a Prebiotic Gel Cream on Its Efficacy of Mild to Moderate Acne Management and Effects on the Functional Skin Microbiome.",
        "journal": "Journal of cosmetic dermatology",
        "publication_date": "2025-10",
        "pubmed_id": "41098119",
        "doi": "10.1111/jocd.70138"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:17:13"
    },
    {
      "id": 32,
      "intervention": {
        "name": "ureteral access sheath (UAS) use during RIRS",
        "canonical_name": "ureteral_access_sheath",
        "category": null,
        "categories": {
          "primary": [
            "medical_device"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "medical_device",
          "layer_1_canonical": "ureteral_access_sheath",
          "layer_2_variant": "ureteral access sheath (UAS) use during RIRS",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "renal stones",
        "canonical_name": "renal stones",
        "category": null,
        "categories": {
          "primary": [
            "urological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "urological",
          "layer_1_canonical": "renal stones",
          "layer_2_variant": "renal stones",
          "layer_3_detail": null
        }
      },
      "mechanism": "facilitates stone removal by providing better access during surgery",
      "mechanism_canonical_names": [
        "surgical access improvement"
      ],
      "correlation": {
        "type": "no_effect",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "retrospective, multicenter cohort study",
        "sample_size": 1177,
        "duration": "January 2017 to December 2018",
        "population": "patients undergoing RIRS for kidney stones",
        "adverse_effects": "increased perioperative morbidity (e.g., longer operative time, higher postoperative stenting)",
        "cost_category": null,
        "study_focus": "impact of ureteral access sheath (UAS) use on perioperative outcomes in ureteroscopy (RIRS)",
        "measured_metrics": [
          "stone-free rate (SFR) at three months",
          "operative time",
          "probability of outpatient procedure",
          "likelihood of postoperative stenting",
          "complication rates (overall and major)"
        ],
        "findings": [
          "Stone-free rate (SFR) at three months was comparable between UAS and no UAS groups (OR = 0.75; 95% CI [0.53-1.08]; p = 0.12)",
          "UAS use was associated with longer operative time (estimate = 3.71 min; 95% CI [1.08-7.32]; p = 0.04)",
          "Lower probability of outpatient procedure with UAS (OR = 0.67; 95% CI [0.49-0.91]; p = 0.01)",
          "Higher likelihood of postoperative stenting with UAS (OR = 3.61; 95% CI [2.72-4.78]; p < 0.001)",
          "No significant differences in overall complications (OR = 1.16; 95% CI [0.68-1.99]; p = 0.57) or major complications (OR = 1.07; 95% CI [0.45-2.57]; p = 0.86)"
        ],
        "study_location": "six academic medical centers (multi-institutional)",
        "publisher": null
      },
      "paper": {
        "title": "Does the use of a ureteral access sheath improve perioperative outcomes in ureteroscopy? A real-world multi-institutional study.",
        "journal": "Urolithiasis",
        "publication_date": "2025-09-29",
        "pubmed_id": "41021049",
        "doi": "10.1007/s00240-025-01865-3"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:28:49"
    },
    {
      "id": 33,
      "intervention": {
        "name": "electroacupuncture",
        "canonical_name": "conventional_and_electroacupuncture",
        "category": null,
        "categories": {
          "primary": [
            "acupuncture"
          ]
        },
        "details": "{}",
        "delivery_method": "acupuncture",
        "hierarchy": {
          "layer_0_category": "acupuncture",
          "layer_1_canonical": "conventional_and_electroacupuncture",
          "layer_2_variant": "electroacupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis pain",
        "canonical_name": "rheumatoid arthritis pain",
        "category": null,
        "categories": {
          "primary": [
            "rheumatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "rheumatological",
          "layer_1_canonical": "rheumatoid arthritis pain",
          "layer_2_variant": "rheumatoid arthritis pain",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced analgesic effects through electrical stimulation",
      "mechanism_canonical_names": [
        "Enhanced analgesic effects via electrical stimulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis of randomized controlled trials",
        "sample_size": 704,
        "duration": null,
        "population": "adults with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "comparative efficacy of electroacupuncture vs conventional acupuncture",
          "placebo control validity in acupuncture trials"
        ],
        "measured_metrics": [
          "visual analog scale (VAS) pain scores",
          "swollen joint count"
        ],
        "findings": [
          "electroacupuncture reduced pain (SMD: -1.42; 95% CI: [-1.87, -0.98])",
          "conventional acupuncture reduced pain (SMD: -1.11; 95% CI: [-1.49, -0.73])",
          "electroacupuncture most effective (97.7% ranking) followed by conventional acupuncture (75.1%)",
          "non-acupoint sham acupuncture showed 29.1% effectiveness"
        ],
        "study_location": null,
        "publisher": "J Integr Med"
      },
      "paper": {
        "title": "Comparative effectiveness of electroacupuncture and conventional acupuncture for rheumatoid arthritis pain: A network meta-analysis with emphasis on placebo control validity.",
        "journal": "Journal of integrative medicine",
        "publication_date": "2025-09-26",
        "pubmed_id": "41102052",
        "doi": "10.1016/j.joim.2025.09.005"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:31:32"
    },
    {
      "id": 34,
      "intervention": {
        "name": "conventional acupuncture",
        "canonical_name": "conventional_and_electroacupuncture",
        "category": null,
        "categories": {
          "primary": [
            "acupuncture"
          ]
        },
        "details": "{}",
        "delivery_method": "acupuncture",
        "hierarchy": {
          "layer_0_category": "acupuncture",
          "layer_1_canonical": "conventional_and_electroacupuncture",
          "layer_2_variant": "conventional acupuncture",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rheumatoid arthritis pain",
        "canonical_name": "rheumatoid arthritis pain",
        "category": null,
        "categories": {
          "primary": [
            "rheumatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "rheumatological",
          "layer_1_canonical": "rheumatoid arthritis pain",
          "layer_2_variant": "rheumatoid arthritis pain",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of pain pathways via acupuncture points",
      "mechanism_canonical_names": [
        "pain pathway modulation via acupuncture"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis of randomized controlled trials",
        "sample_size": 704,
        "duration": null,
        "population": "adults with rheumatoid arthritis",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "comparative efficacy of electroacupuncture vs conventional acupuncture",
          "placebo control validity in acupuncture trials"
        ],
        "measured_metrics": [
          "visual analog scale (VAS) pain scores",
          "swollen joint count"
        ],
        "findings": [
          "electroacupuncture reduced pain (SMD: -1.42; 95% CI: [-1.87, -0.98])",
          "conventional acupuncture reduced pain (SMD: -1.11; 95% CI: [-1.49, -0.73])",
          "electroacupuncture most effective (97.7% ranking) followed by conventional acupuncture (75.1%)",
          "non-acupoint sham acupuncture showed 29.1% effectiveness"
        ],
        "study_location": null,
        "publisher": "J Integr Med"
      },
      "paper": {
        "title": "Comparative effectiveness of electroacupuncture and conventional acupuncture for rheumatoid arthritis pain: A network meta-analysis with emphasis on placebo control validity.",
        "journal": "Journal of integrative medicine",
        "publication_date": "2025-09-26",
        "pubmed_id": "41102052",
        "doi": "10.1016/j.joim.2025.09.005"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:31:32"
    },
    {
      "id": 35,
      "intervention": {
        "name": "double row knotted Corkscrew/Swivelock Biocomposite",
        "canonical_name": "swivelock_biocomposite_corkscrew",
        "category": null,
        "categories": {
          "primary": [
            "surgical_implant"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgical_implant",
          "layer_1_canonical": "swivelock_biocomposite_corkscrew",
          "layer_2_variant": "double row knotted Corkscrew/Swivelock Biocomposite",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": "rotator cuff tear",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "rotator cuff tear",
          "layer_2_variant": "rotator cuff tear",
          "layer_3_detail": null
        }
      },
      "mechanism": "reduced retear rates through improved anchor fixation",
      "mechanism_canonical_names": [
        "improved anchor fixation for tendon repair"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "Markov model economic evaluation",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with rotator cuff tears of varying sizes",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "cost-effectiveness of arthroscopic rotator cuff repair constructs",
          "long-term outcomes of different surgical techniques"
        ],
        "measured_metrics": [
          "cost per quality-adjusted life-year (QALY)",
          "incremental cost-effectiveness ratio (ICER)",
          "retear rates",
          "anchor failure loads"
        ],
        "findings": [
          "for small/medium tears, DR knotted Corkscrew/Swivelock Biocomposite had ICER $12,562/QALY (0.54 QALY gain)",
          "for large tears, DR knotless Swivelock Biocomposite had ICER $19,836/QALY (0.53 QALY gain)",
          "for massive tears, DR knotless Healicoil PEEK/Footprint Ultra PEEK had ICER $27,748/QALY (0.46 QALY gain)",
          "operative management showed increasing cost-effectiveness over 10 years compared to nonoperative care"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:43:17"
    },
    {
      "id": 36,
      "intervention": {
        "name": "double row knotless Swivelock Biocomposite",
        "canonical_name": "swivelock_biocomposite_corkscrew",
        "category": null,
        "categories": {
          "primary": [
            "surgical_implant"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgical_implant",
          "layer_1_canonical": "swivelock_biocomposite_corkscrew",
          "layer_2_variant": "double row knotless Swivelock Biocomposite",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": "rotator cuff tear",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "rotator cuff tear",
          "layer_2_variant": "rotator cuff tear",
          "layer_3_detail": null
        }
      },
      "mechanism": "minimized anchor failure with knotless technology",
      "mechanism_canonical_names": [
        "surgical device improvement"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "Markov model economic evaluation",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with rotator cuff tears of varying sizes",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "cost-effectiveness of arthroscopic rotator cuff repair constructs",
          "long-term outcomes of different surgical techniques"
        ],
        "measured_metrics": [
          "cost per quality-adjusted life-year (QALY)",
          "incremental cost-effectiveness ratio (ICER)",
          "retear rates",
          "anchor failure loads"
        ],
        "findings": [
          "for small/medium tears, DR knotted Corkscrew/Swivelock Biocomposite had ICER $12,562/QALY (0.54 QALY gain)",
          "for large tears, DR knotless Swivelock Biocomposite had ICER $19,836/QALY (0.53 QALY gain)",
          "for massive tears, DR knotless Healicoil PEEK/Footprint Ultra PEEK had ICER $27,748/QALY (0.46 QALY gain)",
          "operative management showed increasing cost-effectiveness over 10 years compared to nonoperative care"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:43:17"
    },
    {
      "id": 37,
      "intervention": {
        "name": "double row knotless Healicoil PEEK/Footprint Ultra PEEK",
        "canonical_name": "healicoil_peek_footprint_ultra_peek",
        "category": null,
        "categories": {
          "primary": [
            "surgical_implant"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgical_implant",
          "layer_1_canonical": "healicoil_peek_footprint_ultra_peek",
          "layer_2_variant": "double row knotless Healicoil PEEK/Footprint Ultra PEEK",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "rotator cuff tear",
        "canonical_name": "rotator cuff tear",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "rotator cuff tear",
          "layer_2_variant": "rotator cuff tear",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced long-term structural integrity for massive tears",
      "mechanism_canonical_names": [
        "tissue repair and structural reinforcement"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "Markov model economic evaluation",
        "sample_size": null,
        "duration": "1, 5, and 10 years",
        "population": "patients with rotator cuff tears of varying sizes",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "cost-effectiveness of arthroscopic rotator cuff repair constructs",
          "long-term outcomes of different surgical techniques"
        ],
        "measured_metrics": [
          "cost per quality-adjusted life-year (QALY)",
          "incremental cost-effectiveness ratio (ICER)",
          "retear rates",
          "anchor failure loads"
        ],
        "findings": [
          "for small/medium tears, DR knotted Corkscrew/Swivelock Biocomposite had ICER $12,562/QALY (0.54 QALY gain)",
          "for large tears, DR knotless Swivelock Biocomposite had ICER $19,836/QALY (0.53 QALY gain)",
          "for massive tears, DR knotless Healicoil PEEK/Footprint Ultra PEEK had ICER $27,748/QALY (0.46 QALY gain)",
          "operative management showed increasing cost-effectiveness over 10 years compared to nonoperative care"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Cost-effectiveness of rotator cuff repair based on modern constructs, tear size, and implant cost at 1, 5, and 10 years.",
        "journal": "JSES international",
        "publication_date": "2025-09",
        "pubmed_id": "41049655",
        "doi": "10.1016/j.jseint.2025.04.038"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:43:17"
    },
    {
      "id": 38,
      "intervention": {
        "name": "topical vancomycin",
        "canonical_name": "topical_vancomycin",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "topical_vancomycin",
          "layer_2_variant": "topical vancomycin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "surgical site infection",
        "canonical_name": "surgical site infection",
        "category": null,
        "categories": {
          "primary": [
            "surgical_infections"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "surgical_infections",
          "layer_1_canonical": "surgical site infection",
          "layer_2_variant": "surgical site infection",
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces bacterial load at wound site",
      "mechanism_canonical_names": [
        "wound site bacterial load reduction"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2982,
        "duration": null,
        "population": "patients with open fractures",
        "adverse_effects": "higher incidence of wound-healing complications",
        "cost_category": null,
        "study_focus": [
          "efficacy of topical antibiotics in reducing SSI",
          "comparison of different topical antibiotic regimens"
        ],
        "measured_metrics": [
          "surgical site infection rates",
          "adverse event incidence",
          "wound-healing complications"
        ],
        "findings": [
          "combined systemic and topical antibiotics reduced SSI rates (7.26% vs 10.12%, p=0.0197)",
          "no significant difference between vancomycin monotherapy and vancomycin+tobramycin (p=0.0602)",
          "no increase in systemic adverse events",
          "vancomycin powder associated with higher wound-healing complications"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Use of Topical Antibiotics in Open Fractures: A Systematic Review and Meta-Analysis.",
        "journal": "Cureus",
        "publication_date": "2025-09",
        "pubmed_id": "41103823",
        "doi": "10.7759/cureus.92261"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:46:24"
    },
    {
      "id": 39,
      "intervention": {
        "name": "topical vancomycin + tobramycin",
        "canonical_name": "topical_vancomycin",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "topical_vancomycin",
          "layer_2_variant": "topical vancomycin + tobramycin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "surgical site infection",
        "canonical_name": "surgical site infection",
        "category": null,
        "categories": {
          "primary": [
            "surgical_infections"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "surgical_infections",
          "layer_1_canonical": "surgical site infection",
          "layer_2_variant": "surgical site infection",
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces bacterial load at wound site",
      "mechanism_canonical_names": [
        "wound site bacterial load reduction"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 2982,
        "duration": null,
        "population": "patients with open fractures",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of topical antibiotics in reducing SSI",
          "comparison of different topical antibiotic regimens"
        ],
        "measured_metrics": [
          "surgical site infection rates",
          "adverse event incidence",
          "wound-healing complications"
        ],
        "findings": [
          "combined systemic and topical antibiotics reduced SSI rates (7.26% vs 10.12%, p=0.0197)",
          "no significant difference between vancomycin monotherapy and vancomycin+tobramycin (p=0.0602)",
          "no increase in systemic adverse events",
          "vancomycin powder associated with higher wound-healing complications"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Use of Topical Antibiotics in Open Fractures: A Systematic Review and Meta-Analysis.",
        "journal": "Cureus",
        "publication_date": "2025-09",
        "pubmed_id": "41103823",
        "doi": "10.7759/cureus.92261"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:46:24"
    },
    {
      "id": 40,
      "intervention": {
        "name": "conventional treatment combined with Bifidobacterium-Lactobacillus triplex live bacteria",
        "canonical_name": "bifidobacterium_live_bacteria_combinations",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "bifidobacterium_live_bacteria_combinations",
          "layer_2_variant": "conventional treatment combined with Bifidobacterium-Lactobacillus triplex live bacteria",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": "asthma",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "asthma",
          "layer_2_variant": "asthma",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates gut microbiota and immune response",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis",
        "sample_size": 3839,
        "duration": null,
        "population": "children with asthma",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of probiotics in asthma treatment",
          "safety of probiotics in children with asthma"
        ],
        "measured_metrics": [
          "lung function (FEV1%)",
          "total clinical response rate",
          "recurrence rate",
          "immune factors (IL-4, IL-33)",
          "cytokines",
          "Childhood Asthma Control Test (C-ACT) score"
        ],
        "findings": [
          "conventional treatment combined with probiotics improved outcome indicators better than conventional treatment alone",
          "Bifidobacterium-Lactobacillus triplex live bacteria showed highest probability for improving FEV1% and reducing recurrence rate",
          "Bifidobacterium adolescentis showed highest probability for improving FEV1",
          "Lactobacillus tablets showed highest probability for improving peak expiratory flow",
          "Bacillus subtilis diplex live bacteria showed highest probability for improving total clinical response rate",
          "Bifidobacterium quadruplex live bacteria showed highest probability for reducing IL-4 and IL-33",
          "Bifidobacterium triplex live bacteria showed highest probability for improving C-ACT score",
          "overall evidence quality was low or moderate"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "A network meta-analysis of",
        "journal": "Frontiers in pediatrics",
        "publication_date": "2025",
        "pubmed_id": "41098501",
        "doi": "10.3389/fped.2025.1637284"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:54:28"
    },
    {
      "id": 41,
      "intervention": {
        "name": "conventional treatment combined with Bifidobacterium adolescentis",
        "canonical_name": "bifidobacterium_live_bacteria_combinations",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "bifidobacterium_live_bacteria_combinations",
          "layer_2_variant": "conventional treatment combined with Bifidobacterium adolescentis",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": "asthma",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "asthma",
          "layer_2_variant": "asthma",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates gut microbiota and immune response",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis",
        "sample_size": 3839,
        "duration": null,
        "population": "children with asthma",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of probiotics in asthma treatment",
          "safety of probiotics in children with asthma"
        ],
        "measured_metrics": [
          "lung function (FEV1%)",
          "total clinical response rate",
          "recurrence rate",
          "immune factors (IL-4, IL-33)",
          "cytokines",
          "Childhood Asthma Control Test (C-ACT) score"
        ],
        "findings": [
          "conventional treatment combined with probiotics improved outcome indicators better than conventional treatment alone",
          "Bifidobacterium-Lactobacillus triplex live bacteria showed highest probability for improving FEV1% and reducing recurrence rate",
          "Bifidobacterium adolescentis showed highest probability for improving FEV1",
          "Lactobacillus tablets showed highest probability for improving peak expiratory flow",
          "Bacillus subtilis diplex live bacteria showed highest probability for improving total clinical response rate",
          "Bifidobacterium quadruplex live bacteria showed highest probability for reducing IL-4 and IL-33",
          "Bifidobacterium triplex live bacteria showed highest probability for improving C-ACT score",
          "overall evidence quality was low or moderate"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "A network meta-analysis of",
        "journal": "Frontiers in pediatrics",
        "publication_date": "2025",
        "pubmed_id": "41098501",
        "doi": "10.3389/fped.2025.1637284"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:54:28"
    },
    {
      "id": 42,
      "intervention": {
        "name": "conventional treatment combined with Lactobacillus tablets",
        "canonical_name": "bacillus_subtilis_diplex_live_bacteria",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "bacillus_subtilis_diplex_live_bacteria",
          "layer_2_variant": "conventional treatment combined with Lactobacillus tablets",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": "asthma",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "asthma",
          "layer_2_variant": "asthma",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates gut microbiota and immune response",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis",
        "sample_size": 3839,
        "duration": null,
        "population": "children with asthma",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of probiotics in asthma treatment",
          "safety of probiotics in children with asthma"
        ],
        "measured_metrics": [
          "lung function (FEV1%)",
          "total clinical response rate",
          "recurrence rate",
          "immune factors (IL-4, IL-33)",
          "cytokines",
          "Childhood Asthma Control Test (C-ACT) score"
        ],
        "findings": [
          "conventional treatment combined with probiotics improved outcome indicators better than conventional treatment alone",
          "Bifidobacterium-Lactobacillus triplex live bacteria showed highest probability for improving FEV1% and reducing recurrence rate",
          "Bifidobacterium adolescentis showed highest probability for improving FEV1",
          "Lactobacillus tablets showed highest probability for improving peak expiratory flow",
          "Bacillus subtilis diplex live bacteria showed highest probability for improving total clinical response rate",
          "Bifidobacterium quadruplex live bacteria showed highest probability for reducing IL-4 and IL-33",
          "Bifidobacterium triplex live bacteria showed highest probability for improving C-ACT score",
          "overall evidence quality was low or moderate"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "A network meta-analysis of",
        "journal": "Frontiers in pediatrics",
        "publication_date": "2025",
        "pubmed_id": "41098501",
        "doi": "10.3389/fped.2025.1637284"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:54:28"
    },
    {
      "id": 43,
      "intervention": {
        "name": "conventional treatment combined with Bacillus subtilis diplex live bacteria",
        "canonical_name": "bacillus_subtilis_diplex_live_bacteria",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "bacillus_subtilis_diplex_live_bacteria",
          "layer_2_variant": "conventional treatment combined with Bacillus subtilis diplex live bacteria",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": "asthma",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "asthma",
          "layer_2_variant": "asthma",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates gut microbiota and immune response",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis",
        "sample_size": 3839,
        "duration": null,
        "population": "children with asthma",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of probiotics in asthma treatment",
          "safety of probiotics in children with asthma"
        ],
        "measured_metrics": [
          "lung function (FEV1%)",
          "total clinical response rate",
          "recurrence rate",
          "immune factors (IL-4, IL-33)",
          "cytokines",
          "Childhood Asthma Control Test (C-ACT) score"
        ],
        "findings": [
          "conventional treatment combined with probiotics improved outcome indicators better than conventional treatment alone",
          "Bifidobacterium-Lactobacillus triplex live bacteria showed highest probability for improving FEV1% and reducing recurrence rate",
          "Bifidobacterium adolescentis showed highest probability for improving FEV1",
          "Lactobacillus tablets showed highest probability for improving peak expiratory flow",
          "Bacillus subtilis diplex live bacteria showed highest probability for improving total clinical response rate",
          "Bifidobacterium quadruplex live bacteria showed highest probability for reducing IL-4 and IL-33",
          "Bifidobacterium triplex live bacteria showed highest probability for improving C-ACT score",
          "overall evidence quality was low or moderate"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "A network meta-analysis of",
        "journal": "Frontiers in pediatrics",
        "publication_date": "2025",
        "pubmed_id": "41098501",
        "doi": "10.3389/fped.2025.1637284"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:54:28"
    },
    {
      "id": 44,
      "intervention": {
        "name": "conventional treatment combined with Bifidobacterium quadruplex live bacteria",
        "canonical_name": "bifidobacterium_live_bacteria_combinations",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "bifidobacterium_live_bacteria_combinations",
          "layer_2_variant": "conventional treatment combined with Bifidobacterium quadruplex live bacteria",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": "asthma",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "asthma",
          "layer_2_variant": "asthma",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates gut microbiota and immune response",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis",
        "sample_size": 3839,
        "duration": null,
        "population": "children with asthma",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of probiotics in asthma treatment",
          "safety of probiotics in children with asthma"
        ],
        "measured_metrics": [
          "lung function (FEV1%)",
          "total clinical response rate",
          "recurrence rate",
          "immune factors (IL-4, IL-33)",
          "cytokines",
          "Childhood Asthma Control Test (C-ACT) score"
        ],
        "findings": [
          "conventional treatment combined with probiotics improved outcome indicators better than conventional treatment alone",
          "Bifidobacterium-Lactobacillus triplex live bacteria showed highest probability for improving FEV1% and reducing recurrence rate",
          "Bifidobacterium adolescentis showed highest probability for improving FEV1",
          "Lactobacillus tablets showed highest probability for improving peak expiratory flow",
          "Bacillus subtilis diplex live bacteria showed highest probability for improving total clinical response rate",
          "Bifidobacterium quadruplex live bacteria showed highest probability for reducing IL-4 and IL-33",
          "Bifidobacterium triplex live bacteria showed highest probability for improving C-ACT score",
          "overall evidence quality was low or moderate"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "A network meta-analysis of",
        "journal": "Frontiers in pediatrics",
        "publication_date": "2025",
        "pubmed_id": "41098501",
        "doi": "10.3389/fped.2025.1637284"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:54:28"
    },
    {
      "id": 45,
      "intervention": {
        "name": "conventional treatment combined with Bifidobacterium triplex live bacteria",
        "canonical_name": "bifidobacterium_live_bacteria_combinations",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "bifidobacterium_live_bacteria_combinations",
          "layer_2_variant": "conventional treatment combined with Bifidobacterium triplex live bacteria",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "asthma",
        "canonical_name": "asthma",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "asthma",
          "layer_2_variant": "asthma",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulates gut microbiota and immune response",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "network meta-analysis",
        "sample_size": 3839,
        "duration": null,
        "population": "children with asthma",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of probiotics in asthma treatment",
          "safety of probiotics in children with asthma"
        ],
        "measured_metrics": [
          "lung function (FEV1%)",
          "total clinical response rate",
          "recurrence rate",
          "immune factors (IL-4, IL-33)",
          "cytokines",
          "Childhood Asthma Control Test (C-ACT) score"
        ],
        "findings": [
          "conventional treatment combined with probiotics improved outcome indicators better than conventional treatment alone",
          "Bifidobacterium-Lactobacillus triplex live bacteria showed highest probability for improving FEV1% and reducing recurrence rate",
          "Bifidobacterium adolescentis showed highest probability for improving FEV1",
          "Lactobacillus tablets showed highest probability for improving peak expiratory flow",
          "Bacillus subtilis diplex live bacteria showed highest probability for improving total clinical response rate",
          "Bifidobacterium quadruplex live bacteria showed highest probability for reducing IL-4 and IL-33",
          "Bifidobacterium triplex live bacteria showed highest probability for improving C-ACT score",
          "overall evidence quality was low or moderate"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "A network meta-analysis of",
        "journal": "Frontiers in pediatrics",
        "publication_date": "2025",
        "pubmed_id": "41098501",
        "doi": "10.3389/fped.2025.1637284"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 15:54:28"
    },
    {
      "id": 46,
      "intervention": {
        "name": "High-Intensity Functional Training (HIFT)",
        "canonical_name": "high_intensity_functional_training",
        "category": null,
        "categories": {
          "primary": [
            "exercise"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "exercise",
          "layer_1_canonical": "high_intensity_functional_training",
          "layer_2_variant": "High-Intensity Functional Training (HIFT)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "obesity",
        "canonical_name": "obesity_severe_obesity",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "obesity_severe_obesity",
          "layer_2_variant": "obesity",
          "layer_3_detail": null
        }
      },
      "mechanism": "improved insulin sensitivity and metabolic health",
      "mechanism_canonical_names": [
        "insulin sensitivity improvement"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 68,
        "duration": "12 weeks",
        "population": "obese males with BMI: 32.6 ± 2.6 kg/m²",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effects of High-Intensity Functional Training (HIFT) and spinach-derived thylakoid supplementation on adipo-myokines, glycemic control, and lipid profiles in obese males",
          "comparison of HIFT alone, thylakoid supplementation alone, and their combination on metabolic parameters"
        ],
        "measured_metrics": [
          "adipo-myokines (CTRP-2, CTRP-9, GDF-8, GDF-15)",
          "insulin resistance (HOMA-IR, plasma glucose, insulin)",
          "lipid profile (HDL-C, LDL-C, triglycerides [TG], total cholesterol [TC])",
          "body composition (BMI, fat mass [FM], fat-free mass [FFM])"
        ],
        "findings": [
          "significant group × time interactions for all variables (p < 0.001) with reductions in adipokine levels (CTRP-9, CTRP-2, GDF-8, GDF-15), BMI, fat mass, LDL-C, TC, TG, insulin, glucose, and HOMA-IR, and increases in HDL-C (p < 0.05)",
          "HIFT+Thyl showed greater improvements in adipo-myokines, lipid profile, glycemic control, and body fat compared to Thyl alone (p < 0.05)",
          "HIFT and HIFT+Thyl had comparable reductions in BMI, fat mass, and improvements in lipid profile and insulin sensitivity"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Impact of using supplemented thylakoids derived from spinach for 12 weeks of high-intensity functional training on adipo-myokines in obese males.",
        "journal": "Frontiers in nutrition",
        "publication_date": "2025",
        "pubmed_id": "41103319",
        "doi": "10.3389/fnut.2025.1513681"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 16:33:25"
    },
    {
      "id": 47,
      "intervention": {
        "name": "Single-anastomosis duodenal switch (SADI-S)",
        "canonical_name": "duodenal_switch_surgery",
        "category": null,
        "categories": {
          "primary": [
            "surgery"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgery",
          "layer_1_canonical": "duodenal_switch_surgery",
          "layer_2_variant": "Single-anastomosis duodenal switch (SADI-S)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe obesity",
        "canonical_name": "obesity_severe_obesity",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "obesity_severe_obesity",
          "layer_2_variant": "severe obesity",
          "layer_3_detail": null
        }
      },
      "mechanism": "greater weight loss through extended malabsorption and gastric restriction",
      "mechanism_canonical_names": [
        "gastric restriction and malabsorption"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized, open-label, multicenter clinical trial",
        "sample_size": 450,
        "duration": "ongoing (protocol stage)",
        "population": "patients aged 18-60 years with BMI 40-50 kg/m²",
        "adverse_effects": "severe malnutrition; diarrhea; dumping; hypoglycemia; surgical reintervention",
        "cost_category": null,
        "study_focus": [
          "comparison of SADI-S and RYGB efficacy",
          "safety profile comparison"
        ],
        "measured_metrics": [
          "percentage of patients with total weight loss (TWL) >30% at 5 years",
          "percentage of patients with severe complications (Clavien-Dindo >2) at 90 days or up to 5 years"
        ],
        "findings": null,
        "study_location": "six hospitals (multicenter)",
        "publisher": null
      },
      "paper": {
        "title": "A randomized open-label multicentre clinical trial comparing single-anastomosis duodenal switch (SADI-S) versus Roux-en-Y gastric bypass for the treatment of severe obesity: BYPSADIS study protocol.",
        "journal": "Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society",
        "publication_date": "2025-10-17",
        "pubmed_id": "41104829",
        "doi": "10.1177/14574969251385873"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:06:57"
    },
    {
      "id": 48,
      "intervention": {
        "name": "Roux-en-Y gastric bypass (RYGB)",
        "canonical_name": "gastric_bypass_surgery",
        "category": null,
        "categories": {
          "primary": [
            "surgery"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgery",
          "layer_1_canonical": "gastric_bypass_surgery",
          "layer_2_variant": "Roux-en-Y gastric bypass (RYGB)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "severe obesity",
        "canonical_name": "obesity_severe_obesity",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "obesity_severe_obesity",
          "layer_2_variant": "severe obesity",
          "layer_3_detail": null
        }
      },
      "mechanism": "weight loss through gastric restriction and partial malabsorption",
      "mechanism_canonical_names": [
        "gastric restriction and malabsorption"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized, open-label, multicenter clinical trial",
        "sample_size": 450,
        "duration": "ongoing (protocol stage)",
        "population": "patients aged 18-60 years with BMI 40-50 kg/m²",
        "adverse_effects": "severe malnutrition; diarrhea; dumping; hypoglycemia; surgical reintervention",
        "cost_category": null,
        "study_focus": [
          "comparison of SADI-S and RYGB efficacy",
          "safety profile comparison"
        ],
        "measured_metrics": [
          "percentage of patients with total weight loss (TWL) >30% at 5 years",
          "percentage of patients with severe complications (Clavien-Dindo >2) at 90 days or up to 5 years"
        ],
        "findings": null,
        "study_location": "six hospitals (multicenter)",
        "publisher": null
      },
      "paper": {
        "title": "A randomized open-label multicentre clinical trial comparing single-anastomosis duodenal switch (SADI-S) versus Roux-en-Y gastric bypass for the treatment of severe obesity: BYPSADIS study protocol.",
        "journal": "Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society",
        "publication_date": "2025-10-17",
        "pubmed_id": "41104829",
        "doi": "10.1177/14574969251385873"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:06:57"
    },
    {
      "id": 49,
      "intervention": {
        "name": "ultrasound-guided pericapsular nerve group (PENG) block",
        "canonical_name": "ultrasound_guided_pericapsular_nerve_group_block",
        "category": null,
        "categories": {
          "primary": [
            "nerve_block"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "nerve_block",
          "layer_1_canonical": "ultrasound_guided_pericapsular_nerve_group_block",
          "layer_2_variant": "ultrasound-guided pericapsular nerve group (PENG) block",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "positional pain during spinal anesthesia in hip fracture patients",
        "canonical_name": "positional_pain_during_spinal_anesthesia_in_hip_fracture_patients",
        "category": null,
        "categories": {
          "primary": [
            "anesthesia"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "anesthesia",
          "layer_1_canonical": "positional_pain_during_spinal_anesthesia_in_hip_fracture_patients",
          "layer_2_variant": "positional pain during spinal anesthesia in hip fracture patients",
          "layer_3_detail": null
        }
      },
      "mechanism": "targeted nerve block reduces pain signals during positioning",
      "mechanism_canonical_names": [
        "targeted nerve block for pain signal reduction"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 62,
        "duration": "8 months (10/1/2024 to 5/25/2025)",
        "population": "ASA II-III patients aged 35–90 years scheduled for hip fracture surgery under spinal anesthesia; excluded patients with contraindications for spinal anesthesia or PENG block, cognitive dysfunction, or previous analgesic use within 12 hours",
        "adverse_effects": "reduced nausea incidence (0%)",
        "cost_category": null,
        "study_focus": [
          "efficacy of ultrasound-guided pericapsular nerve group (PENG) block versus intravenous ketamine in managing positional pain before spinal anesthesia"
        ],
        "measured_metrics": [
          "Numeric Rating Scale (NRS) for pain intensity",
          "Quality of Recovery-15 (QoR-15) for patient satisfaction",
          "total tramadol consumption",
          "incidence of complications"
        ],
        "findings": [
          "PENG block significantly reduced pre-positioning NRS scores (2 vs 4, P<0.001)",
          "PENG block reduced positioning NRS scores (2 vs 5, P<0.001)",
          "PENG block reduced post-positioning NRS scores (2 vs 3, P<0.001) compared to ketamine",
          "PENG group had lower total tramadol consumption (50 mg vs 100 mg, P<0.001)",
          "PENG group had delayed time to first analgesia request (10.5 vs 5.6 hours, P<0.001)",
          "PENG group reported fewer adverse effects (e.g., nausea: 0% vs 12.5%, P=0.045)"
        ],
        "study_location": "Istanbul Training and Research Hospital",
        "publisher": null
      },
      "paper": {
        "title": "Comparison of Ultrasound-Guided Pericapsular Nerve Group Block Versus Intravenous Ketamine for Positional Pain Management Before Spinal Anesthesia in Patients Who Underwent Hip Fracture Surgery: A Randomized Controlled Trial.",
        "journal": "Medical science monitor : international medical journal of experimental and clinical research",
        "publication_date": "2025-10-17",
        "pubmed_id": "41103007",
        "doi": "10.12659/MSM.950517"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:18:56"
    },
    {
      "id": 50,
      "intervention": {
        "name": "antiviral therapies",
        "canonical_name": "antiviral_therapies",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "antiviral_therapies",
          "layer_2_variant": "antiviral therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "influenza",
        "canonical_name": "influenza",
        "category": null,
        "categories": {
          "primary": [
            "infectious_diseases"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "infectious_diseases",
          "layer_1_canonical": "influenza",
          "layer_2_variant": "influenza",
          "layer_3_detail": null
        }
      },
      "mechanism": "directly target viral replication",
      "mechanism_canonical_names": [
        "Direct targeting of viral replication"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "adaptive platform trial",
        "sample_size": null,
        "duration": null,
        "population": "hospitalized patients with influenza",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "evaluation of antiviral therapies for influenza",
          "evaluation of immunomodulatory therapies for influenza"
        ],
        "measured_metrics": null,
        "findings": null,
        "study_location": "global",
        "publisher": null
      },
      "paper": {
        "title": "Platform Trials to Assess Therapeutics in Patients Hospitalized With Influenza.",
        "journal": "The Journal of infectious diseases",
        "publication_date": "2025-10-17",
        "pubmed_id": "41102601",
        "doi": "10.1093/infdis/jiaf276"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:21:38"
    },
    {
      "id": 51,
      "intervention": {
        "name": "immunomodulatory therapies",
        "canonical_name": "antiviral_therapies",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "antiviral_therapies",
          "layer_2_variant": "immunomodulatory therapies",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "influenza",
        "canonical_name": "influenza",
        "category": null,
        "categories": {
          "primary": [
            "infectious_diseases"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "infectious_diseases",
          "layer_1_canonical": "influenza",
          "layer_2_variant": "influenza",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulate immune response to reduce inflammation",
      "mechanism_canonical_names": [
        "immune response modulation"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "adaptive platform trial",
        "sample_size": null,
        "duration": null,
        "population": "hospitalized patients with influenza",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "evaluation of antiviral therapies for influenza",
          "evaluation of immunomodulatory therapies for influenza"
        ],
        "measured_metrics": null,
        "findings": null,
        "study_location": "global",
        "publisher": null
      },
      "paper": {
        "title": "Platform Trials to Assess Therapeutics in Patients Hospitalized With Influenza.",
        "journal": "The Journal of infectious diseases",
        "publication_date": "2025-10-17",
        "pubmed_id": "41102601",
        "doi": "10.1093/infdis/jiaf276"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:21:38"
    },
    {
      "id": 52,
      "intervention": {
        "name": "Bmab 1200 (biosimilar ustekinumab)",
        "canonical_name": "ustekinumab",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "ustekinumab",
          "layer_2_variant": "Bmab 1200 (biosimilar ustekinumab)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": "moderate_to_severe_plaque_psoriasis",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "moderate_to_severe_plaque_psoriasis",
          "layer_2_variant": "moderate-to-severe plaque psoriasis",
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibits interleukin-12 and interleukin-23 pathways",
      "mechanism_canonical_names": [
        "IL-12/23 pathway inhibition"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "Phase 3 randomized controlled trial",
        "sample_size": 324,
        "duration": "52 weeks",
        "population": "patients with moderate-to-severe chronic plaque psoriasis",
        "adverse_effects": "37.8% of patients had at least one treatment-emergent adverse event",
        "cost_category": null,
        "study_focus": "comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab",
        "measured_metrics": [
          "Psoriasis Area and Severity Index (PASI) scores",
          "incidence of treatment-emergent adverse events",
          "post-switch antidrug antibody levels"
        ],
        "findings": [
          "At Week 52, mean PASI reduction was -95.5% (Bmab 1200), -96.6% (continued-reference ustekinumab), and -94.7% (switched-to-Bmab 1200)",
          "Efficacy and safety outcomes were comparable across groups",
          "37.8% of patients had at least one treatment-emergent adverse event",
          "Post-switch antidrug antibody incidence was comparable (Bmab 1200: 63.7%; continued-reference ustekinumab: 80.2%; switched-to-Bmab 1200: 72.6%)"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial.",
        "journal": "Expert opinion on biological therapy",
        "publication_date": "2025-10-16",
        "pubmed_id": "41100115",
        "doi": "10.1080/14712598.2025.2576506"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:36:14"
    },
    {
      "id": 53,
      "intervention": {
        "name": "reference ustekinumab (45 mg or 90 mg)",
        "canonical_name": "ustekinumab",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "ustekinumab",
          "layer_2_variant": "reference ustekinumab (45 mg or 90 mg)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "moderate-to-severe plaque psoriasis",
        "canonical_name": "moderate_to_severe_plaque_psoriasis",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "moderate_to_severe_plaque_psoriasis",
          "layer_2_variant": "moderate-to-severe plaque psoriasis",
          "layer_3_detail": null
        }
      },
      "mechanism": "inhibits interleukin-12 and interleukin-23 pathways",
      "mechanism_canonical_names": [
        "IL-12/23 pathway inhibition"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "Phase 3 randomized controlled trial",
        "sample_size": 324,
        "duration": "52 weeks",
        "population": "patients with moderate-to-severe chronic plaque psoriasis",
        "adverse_effects": "37.8% of patients had at least one treatment-emergent adverse event",
        "cost_category": null,
        "study_focus": "comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab",
        "measured_metrics": [
          "Psoriasis Area and Severity Index (PASI) scores",
          "incidence of treatment-emergent adverse events",
          "post-switch antidrug antibody levels"
        ],
        "findings": [
          "At Week 52, mean PASI reduction was -95.5% (Bmab 1200), -96.6% (continued-reference ustekinumab), and -94.7% (switched-to-Bmab 1200)",
          "Efficacy and safety outcomes were comparable across groups",
          "37.8% of patients had at least one treatment-emergent adverse event",
          "Post-switch antidrug antibody incidence was comparable (Bmab 1200: 63.7%; continued-reference ustekinumab: 80.2%; switched-to-Bmab 1200: 72.6%)"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial.",
        "journal": "Expert opinion on biological therapy",
        "publication_date": "2025-10-16",
        "pubmed_id": "41100115",
        "doi": "10.1080/14712598.2025.2576506"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:36:14"
    },
    {
      "id": 54,
      "intervention": {
        "name": "group cognitive behavioral therapy",
        "canonical_name": "group_cognitive_behavioral_therapy",
        "category": null,
        "categories": {
          "primary": [
            "cognitive_behavioral_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "cognitive_behavioral_therapy",
          "layer_1_canonical": "group_cognitive_behavioral_therapy",
          "layer_2_variant": "group cognitive behavioral therapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "attention-deficit/hyperactivity disorder",
        "canonical_name": "attention-deficit/hyperactivity disorder",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "attention-deficit/hyperactivity disorder",
          "layer_2_variant": "attention-deficit/hyperactivity disorder",
          "layer_3_detail": null
        }
      },
      "mechanism": "improved cognitive-behavioral strategies for symptom management",
      "mechanism_canonical_names": [
        "cognitive-behavioral symptom management"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "retrospective analysis",
        "sample_size": 24,
        "duration": "10 sessions",
        "population": "adults with ADHD (subgroups: FSIQ 90-109, below-average FSIQ, high FSIQ; comorbid depression present/absent)",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effectiveness of group CBT",
          "impact of cognitive ability on treatment response"
        ],
        "measured_metrics": [
          "Adult ADHD Self-Report Scale (ASRS) scores",
          "Korean Adult ADHD Rating Scale (K-AARS) scores",
          "functional impairment (K-AARS impairment subscale)"
        ],
        "findings": [
          "significant improvement in ASRS and K-AARS domains post-intervention",
          "functional impairment improved significantly",
          "average FSIQ (90-109) group showed most consistent improvements",
          "higher attendance correlated with greater symptom reduction",
          "comorbid depression did not affect outcomes"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Effectiveness of Group Cognitive Behavioral Therapy and the Role of Cognitive Ability in Adult Attention-Deficit/Hyperactivity Disorder.",
        "journal": "Psychiatry investigation",
        "publication_date": "2025-10-16",
        "pubmed_id": "41089022",
        "doi": "10.30773/pi.2025.0184"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:38:01"
    },
    {
      "id": 55,
      "intervention": {
        "name": "teriflunomide",
        "canonical_name": "teriflunomide",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "teriflunomide",
          "layer_2_variant": "teriflunomide",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "radiologically isolated syndrome",
        "canonical_name": "radiologically_isolated_syndrome",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "radiologically_isolated_syndrome",
          "layer_2_variant": "radiologically isolated syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of immune response to prevent demyelination",
      "mechanism_canonical_names": [
        "immune modulation for demyelination"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review with meta-analysis",
        "sample_size": 1401,
        "duration": "up to 18 years (cohort studies), 96 weeks (RCTs)",
        "population": "1401 RIS patients (291 received DMTs)",
        "adverse_effects": "increased adverse events (RR=1.44)",
        "cost_category": null,
        "study_focus": [
          "efficacy of DMTs in preventing clinical demyelinating events",
          "safety profile of DMTs in RIS patients"
        ],
        "measured_metrics": [
          "risk of clinical demyelinating events",
          "adverse event incidence",
          "adjusted hazard ratios",
          "risk ratios"
        ],
        "findings": [
          "DMTs reduced clinical demyelinating event risk (adjusted HR=0.37, 95% CI 0.15-0.95)",
          "higher adverse event rates in DMT groups (RR=1.44, 95% CI 1.09-1.90)",
          "21% of 1401 RIS patients received DMTs",
          "no long-term benefits/adverse effects data beyond 5 years"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Disease modifying treatment of radiologically isolated syndrome: A systematic review of the use, efficacy, effectiveness, and safety.",
        "journal": "Revue neurologique",
        "publication_date": "2025-10-15",
        "pubmed_id": "41102030",
        "doi": "10.1016/j.neurol.2025.09.005"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:40:15"
    },
    {
      "id": 56,
      "intervention": {
        "name": "dimethyl fumarate",
        "canonical_name": "dimethyl_fumarate",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "dimethyl_fumarate",
          "layer_2_variant": "dimethyl fumarate",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "radiologically isolated syndrome",
        "canonical_name": "radiologically_isolated_syndrome",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "radiologically_isolated_syndrome",
          "layer_2_variant": "radiologically isolated syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-inflammatory and neuroprotective effects",
      "mechanism_canonical_names": [
        "Anti-inflammatory and antioxidant effects"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review with meta-analysis",
        "sample_size": 1401,
        "duration": "up to 18 years (cohort studies), 96 weeks (RCTs)",
        "population": "1401 RIS patients (291 received DMTs)",
        "adverse_effects": "increased adverse events (RR=1.44)",
        "cost_category": null,
        "study_focus": [
          "efficacy of DMTs in preventing clinical demyelinating events",
          "safety profile of DMTs in RIS patients"
        ],
        "measured_metrics": [
          "risk of clinical demyelinating events",
          "adverse event incidence",
          "adjusted hazard ratios",
          "risk ratios"
        ],
        "findings": [
          "DMTs reduced clinical demyelinating event risk (adjusted HR=0.37, 95% CI 0.15-0.95)",
          "higher adverse event rates in DMT groups (RR=1.44, 95% CI 1.09-1.90)",
          "21% of 1401 RIS patients received DMTs",
          "no long-term benefits/adverse effects data beyond 5 years"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Disease modifying treatment of radiologically isolated syndrome: A systematic review of the use, efficacy, effectiveness, and safety.",
        "journal": "Revue neurologique",
        "publication_date": "2025-10-15",
        "pubmed_id": "41102030",
        "doi": "10.1016/j.neurol.2025.09.005"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:40:15"
    },
    {
      "id": 57,
      "intervention": {
        "name": "trigeminal nerve stimulation (TNS)",
        "canonical_name": "trigeminal_nerve_stimulation",
        "category": null,
        "categories": {
          "primary": [
            "nerve_stimulation"
          ]
        },
        "details": "{}",
        "delivery_method": "neuromodulation",
        "hierarchy": {
          "layer_0_category": "nerve_stimulation",
          "layer_1_canonical": "trigeminal_nerve_stimulation",
          "layer_2_variant": "trigeminal nerve stimulation (TNS)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "drug-resistant epilepsy",
        "canonical_name": "drug-resistant epilepsy",
        "category": null,
        "categories": {
          "primary": [
            "neurological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "neurological",
          "layer_1_canonical": "drug-resistant epilepsy",
          "layer_2_variant": "drug-resistant epilepsy",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of neural pathways to reduce seizure activity",
      "mechanism_canonical_names": [
        "neural pathway modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and meta-analysis",
        "sample_size": 411,
        "duration": "up to 12 months",
        "population": "patients with drug-resistant epilepsy",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of trigeminal nerve stimulation (TNS) in seizure control",
          "safety profile of TNS in DRE patients"
        ],
        "measured_metrics": [
          "response rate (≥50% seizure reduction)",
          "seizure frequency reduction",
          "adverse events"
        ],
        "findings": [
          "significant short-term response rate increase at 3 months (RR 2.03, 95% CI [1.07, 3.84], P=0.03)",
          "borderline seizure frequency reduction at 3 months (RR 2.85, 95% CI [0.99, 8.22], P=0.05)",
          "42% response rate at 3 months (95% CI 30-54%)",
          "mean 29% seizure reduction at 3 months (95% CI 8-51%)",
          "no significant long-term effects at 6/12 months (wide confidence intervals)"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Assessing the efficacy of trigeminal nerve stimulation for drug-resistant epilepsy: A systematic review and meta-analysis.",
        "journal": "Neurosurgical review",
        "publication_date": "2025-10-15",
        "pubmed_id": "41087619",
        "doi": "10.1007/s10143-025-03844-z"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:42:24"
    },
    {
      "id": 58,
      "intervention": {
        "name": "clozapine",
        "canonical_name": "clozapine_quetiapine",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "clozapine_quetiapine",
          "layer_2_variant": "clozapine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": "schizophrenia",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "schizophrenia",
          "layer_2_variant": "schizophrenia",
          "layer_3_detail": null
        }
      },
      "mechanism": "dopamine receptor antagonism",
      "mechanism_canonical_names": [
        "Dopamine and serotonin receptor antagonism"
      ],
      "correlation": {
        "type": "worsens",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": 63,
        "duration": "short-term",
        "population": "adults with first-episode schizophrenia",
        "adverse_effects": "increased somnolence, hypersalivation, constipation",
        "cost_category": null,
        "study_focus": [
          "efficacy comparison of clozapine vs quetiapine",
          "safety profile analysis"
        ],
        "measured_metrics": [
          "global state improvement",
          "relapse rates",
          "metabolic effects",
          "adverse effect incidence",
          "general mental state"
        ],
        "findings": [
          "no significant differences in global state, relapse, or metabolic effects between clozapine and quetiapine",
          "clozapine associated with higher rates of somnolence, hypersalivation, and constipation",
          "no significant differences in other adverse effects or early discontinuation rates"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review.",
        "journal": "Psychiatry research",
        "publication_date": "2025-10-15",
        "pubmed_id": "41101242",
        "doi": "10.1016/j.psychres.2025.116764"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:47:51"
    },
    {
      "id": 59,
      "intervention": {
        "name": "quetiapine",
        "canonical_name": "clozapine_quetiapine",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "clozapine_quetiapine",
          "layer_2_variant": "quetiapine",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "schizophrenia",
        "canonical_name": "schizophrenia",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "schizophrenia",
          "layer_2_variant": "schizophrenia",
          "layer_3_detail": null
        }
      },
      "mechanism": "serotonin and dopamine receptor antagonism",
      "mechanism_canonical_names": [
        "Dopamine and serotonin receptor antagonism"
      ],
      "correlation": {
        "type": "no_effect",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": 63,
        "duration": "short-term",
        "population": "adults with first-episode schizophrenia",
        "adverse_effects": "no significant differences in adverse effects compared to clozapine",
        "cost_category": null,
        "study_focus": [
          "efficacy comparison of clozapine vs quetiapine",
          "safety profile analysis"
        ],
        "measured_metrics": [
          "global state improvement",
          "relapse rates",
          "metabolic effects",
          "adverse effect incidence",
          "general mental state"
        ],
        "findings": [
          "no significant differences in global state, relapse, or metabolic effects between clozapine and quetiapine",
          "clozapine associated with higher rates of somnolence, hypersalivation, and constipation",
          "no significant differences in other adverse effects or early discontinuation rates"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review.",
        "journal": "Psychiatry research",
        "publication_date": "2025-10-15",
        "pubmed_id": "41101242",
        "doi": "10.1016/j.psychres.2025.116764"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 20:47:51"
    },
    {
      "id": 60,
      "intervention": {
        "name": "upfront surgical resection (RND)",
        "canonical_name": "upfront_surgical_resection",
        "category": null,
        "categories": {
          "primary": [
            "surgery"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgery",
          "layer_1_canonical": "upfront_surgical_resection",
          "layer_2_variant": "upfront surgical resection (RND)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "retroperitoneal lymph node metastases in colorectal cancer",
        "canonical_name": "retroperitoneal_lymph_node_metastases_in_colorectal_cancer",
        "category": null,
        "categories": {
          "primary": [
            "oncological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "oncological",
          "layer_1_canonical": "retroperitoneal_lymph_node_metastases_in_colorectal_cancer",
          "layer_2_variant": "retroperitoneal lymph node metastases in colorectal cancer",
          "layer_3_detail": null
        }
      },
      "mechanism": "direct removal of metastatic lymph nodes",
      "mechanism_canonical_names": [
        "Direct removal of metastatic lymph nodes"
      ],
      "correlation": {
        "type": "no_effect",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "retrospective observational study",
        "sample_size": 54,
        "duration": "2000-2023",
        "population": "54 patients (32 males, 22 females, mean age 51) with sub-renal RLNM from CRC",
        "adverse_effects": "not explicitly reported",
        "cost_category": null,
        "study_focus": [
          "comparison of multimodal treatment strategies",
          "oncologic outcomes of RCT-surgery vs surgery-alone"
        ],
        "measured_metrics": [
          "overall survival (OS)",
          "recurrence-free survival (RFS)",
          "morbidity rates",
          "complete response rates"
        ],
        "findings": [
          "preoperative RCT associated with higher complete response rate (18.2% vs 0%, p=0.018)",
          "median OS not reached in RCT-surgery group vs 73.9 months in surgery-alone group (p=0.909)",
          "median RFS 13.1 months (RCT-surgery) vs 8.6 months (surgery-alone, p=0.153)",
          "similar morbidity, mortality, and hospital stay between groups"
        ],
        "study_location": "single-center (unspecified location)",
        "publisher": null
      },
      "paper": {
        "title": "Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis.",
        "journal": "Annals of surgical oncology",
        "publication_date": "2025-10-14",
        "pubmed_id": "41087778",
        "doi": "10.1245/s10434-025-18106-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:00:23"
    },
    {
      "id": 61,
      "intervention": {
        "name": "One Anastomosis Gastric Bypass (OAGB)",
        "canonical_name": "gastric_bypass_surgery",
        "category": null,
        "categories": {
          "primary": [
            "surgery"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgery",
          "layer_1_canonical": "gastric_bypass_surgery",
          "layer_2_variant": "One Anastomosis Gastric Bypass (OAGB)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "obesity",
        "canonical_name": "obesity_severe_obesity",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "obesity_severe_obesity",
          "layer_2_variant": "obesity",
          "layer_3_detail": null
        }
      },
      "mechanism": "restricts food intake and alters gut hormone signaling",
      "mechanism_canonical_names": [
        "gut hormone signaling alteration for appetite suppression"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "scoping review",
        "sample_size": 67,
        "duration": null,
        "population": "adults undergoing OAGB",
        "adverse_effects": "increased GERD risk, nutritional deficiencies, complications variability",
        "cost_category": null,
        "study_focus": [
          "%EWL outcomes",
          "metabolic disease remission",
          "postoperative complications",
          "GERD incidence"
        ],
        "measured_metrics": [
          "%EWL",
          "type 2 diabetes remission rates",
          "hypertension improvement rates",
          "GERD incidence",
          "complication rates"
        ],
        "findings": [
          "OAGB showed higher or comparable %EWL vs RYGB, SG, SADI-S in short/mid-term follow-up",
          "type 2 diabetes remission 76.8-100%",
          "improvements in hypertension, dyslipidemia, obstructive sleep apnea",
          "GERD incidence influenced by limb length, hiatal hernia, surgical technique",
          "longer biliopancreatic limbs increased weight loss but raised nutritional risk"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "One anastomosis gastric bypass (OAGB): a scoping review.",
        "journal": "BMC surgery",
        "publication_date": "2025-10-10",
        "pubmed_id": "41074037",
        "doi": "10.1186/s12893-025-03215-x"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:12:46"
    },
    {
      "id": 62,
      "intervention": {
        "name": "Renal Combi supplement",
        "canonical_name": "renal_combi_supplement",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "renal_combi_supplement",
          "layer_2_variant": "Renal Combi supplement",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic kidney disease",
        "canonical_name": "chronic kidney disease",
        "category": null,
        "categories": {
          "primary": [
            "renal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "renal",
          "layer_1_canonical": "chronic kidney disease",
          "layer_2_variant": "chronic kidney disease",
          "layer_3_detail": null
        }
      },
      "mechanism": "reduces proteinuria and phosphorus levels through metabolic support",
      "mechanism_canonical_names": [
        "metabolic support for proteinuria and phosphorus reduction"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 30,
        "duration": "90 days",
        "population": "30 dogs diagnosed with chronic kidney disease",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "effectiveness of renal supplement in managing CKD",
          "impact on metabolic and renal markers"
        ],
        "measured_metrics": [
          "proteinuria levels",
          "blood urea levels",
          "phosphorus levels",
          "creatinine levels",
          "SDMA levels",
          "blood pressure",
          "systemic inflammation markers",
          "oxidative stress markers"
        ],
        "findings": [
          "reduced proteinuria, blood urea, and phosphorus levels",
          "stabilized creatinine and SDMA levels",
          "maintained blood pressure",
          "improved systemic inflammation and oxidative stress markers"
        ],
        "study_location": "Italy",
        "publisher": null
      },
      "paper": {
        "title": "Efficacy of a Once-Daily Supplement in Managing Canine Chronic Kidney Disease.",
        "journal": "Animals : an open access journal from MDPI",
        "publication_date": "2025-10-02",
        "pubmed_id": "41096479",
        "doi": "10.3390/ani15192884"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:50:27"
    },
    {
      "id": 63,
      "intervention": {
        "name": "user-centered COPD care pathway",
        "canonical_name": "user_centered_copd_care_pathway",
        "category": null,
        "categories": {
          "primary": [
            "care_pathway"
          ]
        },
        "details": "{}",
        "delivery_method": null,
        "hierarchy": {
          "layer_0_category": "care_pathway",
          "layer_1_canonical": "user_centered_copd_care_pathway",
          "layer_2_variant": "user-centered COPD care pathway",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "chronic obstructive pulmonary disease",
        "canonical_name": "chronic obstructive pulmonary disease",
        "category": null,
        "categories": {
          "primary": [
            "respiratory"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "respiratory",
          "layer_1_canonical": "chronic obstructive pulmonary disease",
          "layer_2_variant": "chronic obstructive pulmonary disease",
          "layer_3_detail": null
        }
      },
      "mechanism": "integrates patient data into personalized care workflow",
      "mechanism_canonical_names": [
        "personalized care integration"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "mixed-methods clinical trial protocol",
        "sample_size": null,
        "duration": null,
        "population": "patients with cancer receiving immune checkpoint inhibitors",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "care pathway design for COPD in cancer patients",
          "treatment burden measurement"
        ],
        "measured_metrics": [
          "disease burden quantification",
          "care components analysis",
          "barriers identification"
        ],
        "findings": [
          "identified critical need for COPD care optimization in oncology clinics",
          "quantified COPD treatment burdens",
          "mapped care components and barriers in medical oncology clinics"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "User-centered design of a COPD care pathway for patients with cancer: a mixed-methods clinical trial protocol.",
        "journal": "Future oncology (London, England)",
        "publication_date": "2025-10",
        "pubmed_id": "41084760",
        "doi": "10.1080/14796694.2025.2562715"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:57:04"
    },
    {
      "id": 64,
      "intervention": {
        "name": "micronized adipose tissue",
        "canonical_name": "micronized_adipose_tissue",
        "category": null,
        "categories": {
          "primary": [
            "tissue_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "tissue_therapy",
          "layer_1_canonical": "micronized_adipose_tissue",
          "layer_2_variant": "micronized adipose tissue",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": "knee osteoarthritis",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "knee osteoarthritis",
          "layer_2_variant": "knee osteoarthritis",
          "layer_3_detail": null
        }
      },
      "mechanism": "tissue healing and anti-inflammatory effects",
      "mechanism_canonical_names": [
        "anti-inflammatory and tissue healing effects"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "short-term",
        "population": "patients with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of adipose-derived therapies in improving pain and function",
          "safety evaluation of adipose-derived therapies"
        ],
        "measured_metrics": [
          "pain levels",
          "functional outcomes",
          "adverse event incidence"
        ],
        "findings": [
          "adipose-derived therapies improve pain and function in patients with knee osteoarthritis",
          "short-term follow-up data available",
          "variability in preparation methods and cell concentration across studies"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Adipose-Derived Therapies for the Treatment of Knee Osteoarthritis: Do They Work and Are They Safe?",
        "journal": "Clinics in sports medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41101905",
        "doi": "10.1016/j.csm.2025.01.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:59:18"
    },
    {
      "id": 65,
      "intervention": {
        "name": "enzymatically extracted stromal vascular fraction",
        "canonical_name": "enzymatically_extracted_stromal_vascular_fraction",
        "category": null,
        "categories": {
          "primary": [
            "gene_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "gene_therapy",
          "layer_1_canonical": "enzymatically_extracted_stromal_vascular_fraction",
          "layer_2_variant": "enzymatically extracted stromal vascular fraction",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": "knee osteoarthritis",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "knee osteoarthritis",
          "layer_2_variant": "knee osteoarthritis",
          "layer_3_detail": null
        }
      },
      "mechanism": "release of growth factors and anti-inflammatory mediators",
      "mechanism_canonical_names": [
        "growth factor release and anti-inflammatory effects"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "short-term",
        "population": "patients with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of adipose-derived therapies in improving pain and function",
          "safety evaluation of adipose-derived therapies"
        ],
        "measured_metrics": [
          "pain levels",
          "functional outcomes",
          "adverse event incidence"
        ],
        "findings": [
          "adipose-derived therapies improve pain and function in patients with knee osteoarthritis",
          "short-term follow-up data available",
          "variability in preparation methods and cell concentration across studies"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Adipose-Derived Therapies for the Treatment of Knee Osteoarthritis: Do They Work and Are They Safe?",
        "journal": "Clinics in sports medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41101905",
        "doi": "10.1016/j.csm.2025.01.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:59:18"
    },
    {
      "id": 66,
      "intervention": {
        "name": "culture-expanded adipose-derived stromal cells",
        "canonical_name": "culture_expanded_adipose_derived_stromal_cells",
        "category": null,
        "categories": {
          "primary": [
            "gene_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "injection",
        "hierarchy": {
          "layer_0_category": "gene_therapy",
          "layer_1_canonical": "culture_expanded_adipose_derived_stromal_cells",
          "layer_2_variant": "culture-expanded adipose-derived stromal cells",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "knee osteoarthritis",
        "canonical_name": "knee osteoarthritis",
        "category": null,
        "categories": {
          "primary": [
            "musculoskeletal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "musculoskeletal",
          "layer_1_canonical": "knee osteoarthritis",
          "layer_2_variant": "knee osteoarthritis",
          "layer_3_detail": null
        }
      },
      "mechanism": "cell-based tissue regeneration and immunomodulation",
      "mechanism_canonical_names": [
        "Cell-based tissue regeneration and immunomodulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": null,
        "duration": "short-term",
        "population": "patients with knee osteoarthritis",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of adipose-derived therapies in improving pain and function",
          "safety evaluation of adipose-derived therapies"
        ],
        "measured_metrics": [
          "pain levels",
          "functional outcomes",
          "adverse event incidence"
        ],
        "findings": [
          "adipose-derived therapies improve pain and function in patients with knee osteoarthritis",
          "short-term follow-up data available",
          "variability in preparation methods and cell concentration across studies"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Adipose-Derived Therapies for the Treatment of Knee Osteoarthritis: Do They Work and Are They Safe?",
        "journal": "Clinics in sports medicine",
        "publication_date": "2025-10",
        "pubmed_id": "41101905",
        "doi": "10.1016/j.csm.2025.01.006"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 21:59:18"
    },
    {
      "id": 67,
      "intervention": {
        "name": "peppermint oil",
        "canonical_name": "fennel_oil_peppermint_oil",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "fennel_oil_peppermint_oil",
          "layer_2_variant": "peppermint oil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": "irritable bowel syndrome",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "irritable bowel syndrome",
          "layer_2_variant": "irritable bowel syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "antispasmodic action on gastrointestinal smooth muscle",
      "mechanism_canonical_names": [
        "Antispasmodic action on gastrointestinal smooth muscle"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBS patients",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of herbal remedies for symptom relief",
          "mechanisms of herbal treatments"
        ],
        "measured_metrics": [
          "symptom relief (abdominal pain, bowel habits)",
          "anti-inflammatory activity",
          "antispasmodic effects"
        ],
        "findings": [
          "peppermint oil and Iberogast showed efficacy in RCTs",
          "preclinical studies demonstrate anti-inflammatory and antispasmodic effects for curcumin, fennel oil, and cannabis derivatives",
          "limited evidence for long-term safety and herb-drug interactions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-24",
        "pubmed_id": "41096612",
        "doi": "10.3390/ijms26199345"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:18:02"
    },
    {
      "id": 68,
      "intervention": {
        "name": "Iberogast",
        "canonical_name": "iberogast",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "iberogast",
          "layer_2_variant": "Iberogast",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": "irritable bowel syndrome",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "irritable bowel syndrome",
          "layer_2_variant": "irritable bowel syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "multi-herb formulation with anti-inflammatory and antispasmodic properties",
      "mechanism_canonical_names": [
        "herbal anti-inflammatory and antispasmodic"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBS patients",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of herbal remedies for symptom relief",
          "mechanisms of herbal treatments"
        ],
        "measured_metrics": [
          "symptom relief (abdominal pain, bowel habits)",
          "anti-inflammatory activity",
          "antispasmodic effects"
        ],
        "findings": [
          "peppermint oil and Iberogast showed efficacy in RCTs",
          "preclinical studies demonstrate anti-inflammatory and antispasmodic effects for curcumin, fennel oil, and cannabis derivatives",
          "limited evidence for long-term safety and herb-drug interactions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-24",
        "pubmed_id": "41096612",
        "doi": "10.3390/ijms26199345"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:18:02"
    },
    {
      "id": 69,
      "intervention": {
        "name": "curcumin",
        "canonical_name": "curcumin",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "curcumin",
          "layer_2_variant": "curcumin",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": "irritable bowel syndrome",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "irritable bowel syndrome",
          "layer_2_variant": "irritable bowel syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "anti-inflammatory and antioxidant effects",
      "mechanism_canonical_names": [
        "Anti-inflammatory and antioxidant effects"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBS patients",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of herbal remedies for symptom relief",
          "mechanisms of herbal treatments"
        ],
        "measured_metrics": [
          "symptom relief (abdominal pain, bowel habits)",
          "anti-inflammatory activity",
          "antispasmodic effects"
        ],
        "findings": [
          "peppermint oil and Iberogast showed efficacy in RCTs",
          "preclinical studies demonstrate anti-inflammatory and antispasmodic effects for curcumin, fennel oil, and cannabis derivatives",
          "limited evidence for long-term safety and herb-drug interactions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-24",
        "pubmed_id": "41096612",
        "doi": "10.3390/ijms26199345"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:18:02"
    },
    {
      "id": 70,
      "intervention": {
        "name": "fennel oil",
        "canonical_name": "fennel_oil_peppermint_oil",
        "category": null,
        "categories": {
          "primary": [
            "supplement"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "supplement",
          "layer_1_canonical": "fennel_oil_peppermint_oil",
          "layer_2_variant": "fennel oil",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": "irritable bowel syndrome",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "irritable bowel syndrome",
          "layer_2_variant": "irritable bowel syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "antispasmodic and digestive stimulant properties",
      "mechanism_canonical_names": [
        "Antispasmodic action on gastrointestinal smooth muscle"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBS patients",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of herbal remedies for symptom relief",
          "mechanisms of herbal treatments"
        ],
        "measured_metrics": [
          "symptom relief (abdominal pain, bowel habits)",
          "anti-inflammatory activity",
          "antispasmodic effects"
        ],
        "findings": [
          "peppermint oil and Iberogast showed efficacy in RCTs",
          "preclinical studies demonstrate anti-inflammatory and antispasmodic effects for curcumin, fennel oil, and cannabis derivatives",
          "limited evidence for long-term safety and herb-drug interactions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-24",
        "pubmed_id": "41096612",
        "doi": "10.3390/ijms26199345"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:18:02"
    },
    {
      "id": 71,
      "intervention": {
        "name": "cannabis derivatives",
        "canonical_name": "cannabis_derivatives",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "cannabis_derivatives",
          "layer_2_variant": "cannabis derivatives",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "irritable bowel syndrome",
        "canonical_name": "irritable bowel syndrome",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "irritable bowel syndrome",
          "layer_2_variant": "irritable bowel syndrome",
          "layer_3_detail": null
        }
      },
      "mechanism": "modulation of endocannabinoid system with anti-inflammatory effects",
      "mechanism_canonical_names": [
        "endocannabinoid modulation"
      ],
      "correlation": {
        "type": "inconclusive",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review",
        "sample_size": null,
        "duration": null,
        "population": "IBS patients",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of herbal remedies for symptom relief",
          "mechanisms of herbal treatments"
        ],
        "measured_metrics": [
          "symptom relief (abdominal pain, bowel habits)",
          "anti-inflammatory activity",
          "antispasmodic effects"
        ],
        "findings": [
          "peppermint oil and Iberogast showed efficacy in RCTs",
          "preclinical studies demonstrate anti-inflammatory and antispasmodic effects for curcumin, fennel oil, and cannabis derivatives",
          "limited evidence for long-term safety and herb-drug interactions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.",
        "journal": "International journal of molecular sciences",
        "publication_date": "2025-09-24",
        "pubmed_id": "41096612",
        "doi": "10.3390/ijms26199345"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:18:02"
    },
    {
      "id": 72,
      "intervention": {
        "name": "Mohs Micrographic Surgery (MMS)",
        "canonical_name": "mohs_micrographic_surgery",
        "category": null,
        "categories": {
          "primary": [
            "surgery"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "surgery",
          "layer_1_canonical": "mohs_micrographic_surgery",
          "layer_2_variant": "Mohs Micrographic Surgery (MMS)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-melanoma skin cancer",
        "canonical_name": "non_melanoma_skin_cancer",
        "category": null,
        "categories": {
          "primary": [
            "oncological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "oncological",
          "layer_1_canonical": "non_melanoma_skin_cancer",
          "layer_2_variant": "non-melanoma skin cancer",
          "layer_3_detail": null
        }
      },
      "mechanism": "precise margin evaluation with 100% histological confirmation of tumor clearance",
      "mechanism_canonical_names": [
        "histological tumor margin evaluation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "review article",
        "sample_size": null,
        "duration": null,
        "population": "patients with basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and other non-melanoma skin cancers",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy and mechanisms of surgical therapies",
          "mechanisms of action of topical and systemic treatments",
          "role of immunotherapy in advanced SCC"
        ],
        "measured_metrics": [
          "cure rates",
          "tumor size reduction",
          "recurrence rates",
          "immune response markers"
        ],
        "findings": [
          "Mohs Micrographic Surgery (MMS) achieves 100% margin evaluation with cure rates of 70-99% when wide margins are obtained",
          "Imiquimod activates TLR7/8, inducing pro-inflammatory cytokines (IFN-α, TNF-α, IL-12) and anti-tumor immune responses",
          "Radiation therapy (RTh) induces DNA damage and ROS production, leading to tumor cell death",
          "Cemiplimab (PD-1 inhibitor) reduced tumor size in 50% of locally advanced/metastatic SCC patients and lowered recurrence risks in adjuvant therapy"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:21:30"
    },
    {
      "id": 73,
      "intervention": {
        "name": "Imiquimod topical cream",
        "canonical_name": "imiquimod_topical_cream",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "imiquimod_topical_cream",
          "layer_2_variant": "Imiquimod topical cream",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "non-melanoma skin cancer",
        "canonical_name": "non_melanoma_skin_cancer",
        "category": null,
        "categories": {
          "primary": [
            "oncological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "oncological",
          "layer_1_canonical": "non_melanoma_skin_cancer",
          "layer_2_variant": "non-melanoma skin cancer",
          "layer_3_detail": null
        }
      },
      "mechanism": "activates TLR7/8 on immune cells, triggering NF-κB/IRF pathways and pro-inflammatory cytokine production (IFN-α, TNF-α, IL-12)",
      "mechanism_canonical_names": [
        "TLR7/8 activation and pro-inflammatory cytokine production"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "review article",
        "sample_size": null,
        "duration": null,
        "population": "patients with basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and other non-melanoma skin cancers",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy and mechanisms of surgical therapies",
          "mechanisms of action of topical and systemic treatments",
          "role of immunotherapy in advanced SCC"
        ],
        "measured_metrics": [
          "cure rates",
          "tumor size reduction",
          "recurrence rates",
          "immune response markers"
        ],
        "findings": [
          "Mohs Micrographic Surgery (MMS) achieves 100% margin evaluation with cure rates of 70-99% when wide margins are obtained",
          "Imiquimod activates TLR7/8, inducing pro-inflammatory cytokines (IFN-α, TNF-α, IL-12) and anti-tumor immune responses",
          "Radiation therapy (RTh) induces DNA damage and ROS production, leading to tumor cell death",
          "Cemiplimab (PD-1 inhibitor) reduced tumor size in 50% of locally advanced/metastatic SCC patients and lowered recurrence risks in adjuvant therapy"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer.",
        "journal": "Life (Basel, Switzerland)",
        "publication_date": "2025-09-16",
        "pubmed_id": "41010389",
        "doi": "10.3390/life15091447"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:21:30"
    },
    {
      "id": 74,
      "intervention": {
        "name": "autologous platelet-rich plasma (PRP) injection",
        "canonical_name": "platelet_rich_plasma_injection",
        "category": null,
        "categories": {
          "primary": [
            "regenerative_medicine"
          ]
        },
        "details": "{}",
        "delivery_method": "surgical",
        "hierarchy": {
          "layer_0_category": "regenerative_medicine",
          "layer_1_canonical": "platelet_rich_plasma_injection",
          "layer_2_variant": "autologous platelet-rich plasma (PRP) injection",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "thyroidectomy scar",
        "canonical_name": "thyroidectomy_scar",
        "category": null,
        "categories": {
          "primary": [
            "dermatological"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "dermatological",
          "layer_1_canonical": "thyroidectomy_scar",
          "layer_2_variant": "thyroidectomy scar",
          "layer_3_detail": null
        }
      },
      "mechanism": "growth factors enhance wound healing and modulate scar formation",
      "mechanism_canonical_names": [
        "wound healing modulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "prospective randomized interventional study",
        "sample_size": 32,
        "duration": "18 months",
        "population": "32 patients aged 18-50 undergoing conventional thyroidectomy",
        "adverse_effects": "not reported",
        "cost_category": null,
        "study_focus": [
          "scar quality improvement",
          "pain reduction in post-thyroidectomy scars"
        ],
        "measured_metrics": [
          "Patient and Observer Scar Assessment Scale (POSAS) scores",
          "scar pain levels",
          "pigmentation difference",
          "scar thickness",
          "vascularity",
          "pliability"
        ],
        "findings": [
          "PRP group had significantly less scar pain (1.06 vs 1.75, p=0.002)",
          "reduced pigmentation difference (1.81 vs 2.31, p=0.032)",
          "decreased scar thickness (1.75 vs 2.12, p=0.033)",
          "lower total POSAS patient score (8.81 vs 10.56, p=0.012)",
          "reduced vascularity (1.06 vs 2.31, p=0.001)",
          "improved pigmentation (1.81 vs 2.43, p=0.031)",
          "enhanced pliability (1.43 vs 1.87, p=0.021)",
          "lower total POSAS observer score (9.12 vs 12.18, p=0.003)"
        ],
        "study_location": "New Delhi, India",
        "publisher": null
      },
      "paper": {
        "title": "Effect of Autologous Platelet-Rich Plasma on Thyroidectomy Scars: A Prospective Interventional Study in a Tertiary Care Hospital in India.",
        "journal": "Cureus",
        "publication_date": "2025-06",
        "pubmed_id": "40621269",
        "doi": "10.7759/cureus.85404"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:36:30"
    },
    {
      "id": 75,
      "intervention": {
        "name": "bismuth-containing quadruple therapy (BQT)",
        "canonical_name": "bismuth_quadruple_therapy",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "bismuth_quadruple_therapy",
          "layer_2_variant": "bismuth-containing quadruple therapy (BQT)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": "Helicobacter pylori infection",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "Helicobacter pylori infection",
          "layer_2_variant": "Helicobacter pylori infection",
          "layer_3_detail": null
        }
      },
      "mechanism": "multidrug regimen targeting H. pylori eradication",
      "mechanism_canonical_names": [
        "H. pylori eradication through multidrug regimen"
      ],
      "correlation": {
        "type": "no_effect",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 468,
        "duration": "14 days",
        "population": "treatment-naïve adult patients with confirmed H. pylori infection",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of tegoprazan-based therapies",
          "comparison with bismuth-containing quadruple therapy"
        ],
        "measured_metrics": [
          "H. pylori eradication rates",
          "adverse event incidence",
          "treatment compliance"
        ],
        "findings": [
          "TBQT eradication rate 86.3% (ITT), 87.3% (PP)",
          "TAD eradication rate 85.5% (ITT), 87.2% (PP)",
          "BQT eradication rate 77.2% (ITT), 77.7% (PP)",
          "adverse events comparable between groups",
          "similar compliance across all groups"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Tegoprazan dual and quadruple therapy for",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "40873796",
        "doi": "10.3389/fmed.2025.1629567"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:39:17"
    },
    {
      "id": 76,
      "intervention": {
        "name": "tegoprazan-amoxicillin dual therapy (TAD)",
        "canonical_name": "tegoprazan_amoxicillin_dual_therapy",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "tegoprazan_amoxicillin_dual_therapy",
          "layer_2_variant": "tegoprazan-amoxicillin dual therapy (TAD)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": "Helicobacter pylori infection",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "Helicobacter pylori infection",
          "layer_2_variant": "Helicobacter pylori infection",
          "layer_3_detail": null
        }
      },
      "mechanism": "dual-action eradication regimen",
      "mechanism_canonical_names": [
        "Dual-action eradication regimen"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 468,
        "duration": "14 days",
        "population": "treatment-naïve adult patients with confirmed H. pylori infection",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of tegoprazan-based therapies",
          "comparison with bismuth-containing quadruple therapy"
        ],
        "measured_metrics": [
          "H. pylori eradication rates",
          "adverse event incidence",
          "treatment compliance"
        ],
        "findings": [
          "TBQT eradication rate 86.3% (ITT), 87.3% (PP)",
          "TAD eradication rate 85.5% (ITT), 87.2% (PP)",
          "BQT eradication rate 77.2% (ITT), 77.7% (PP)",
          "adverse events comparable between groups",
          "similar compliance across all groups"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Tegoprazan dual and quadruple therapy for",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "40873796",
        "doi": "10.3389/fmed.2025.1629567"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:39:17"
    },
    {
      "id": 77,
      "intervention": {
        "name": "tegoprazan-based quadruple therapy (TBQT)",
        "canonical_name": "bismuth_quadruple_therapy",
        "category": null,
        "categories": {
          "primary": [
            "medication"
          ]
        },
        "details": "{}",
        "delivery_method": "oral",
        "hierarchy": {
          "layer_0_category": "medication",
          "layer_1_canonical": "bismuth_quadruple_therapy",
          "layer_2_variant": "tegoprazan-based quadruple therapy (TBQT)",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "Helicobacter pylori infection",
        "canonical_name": "Helicobacter pylori infection",
        "category": null,
        "categories": {
          "primary": [
            "gastrointestinal"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "gastrointestinal",
          "layer_1_canonical": "Helicobacter pylori infection",
          "layer_2_variant": "Helicobacter pylori infection",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced multidrug regimen with tegoprazan",
      "mechanism_canonical_names": [
        "gastric acid suppression with tegoprazan"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial",
        "sample_size": 468,
        "duration": "14 days",
        "population": "treatment-naïve adult patients with confirmed H. pylori infection",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "efficacy of tegoprazan-based therapies",
          "comparison with bismuth-containing quadruple therapy"
        ],
        "measured_metrics": [
          "H. pylori eradication rates",
          "adverse event incidence",
          "treatment compliance"
        ],
        "findings": [
          "TBQT eradication rate 86.3% (ITT), 87.3% (PP)",
          "TAD eradication rate 85.5% (ITT), 87.2% (PP)",
          "BQT eradication rate 77.2% (ITT), 77.7% (PP)",
          "adverse events comparable between groups",
          "similar compliance across all groups"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Tegoprazan dual and quadruple therapy for",
        "journal": "Frontiers in medicine",
        "publication_date": "2025",
        "pubmed_id": "40873796",
        "doi": "10.3389/fmed.2025.1629567"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:39:17"
    },
    {
      "id": 78,
      "intervention": {
        "name": "antimicrobial dressings (silver ion) with basic fibroblast growth factor",
        "canonical_name": "antimicrobial_dressings",
        "category": null,
        "categories": {
          "primary": [
            "topical_medical_device"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "topical_medical_device",
          "layer_1_canonical": "antimicrobial_dressings",
          "layer_2_variant": "antimicrobial dressings (silver ion) with basic fibroblast growth factor",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic foot ulcers",
        "canonical_name": "diabetic foot ulcers",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "diabetic foot ulcers",
          "layer_2_variant": "diabetic foot ulcers",
          "layer_3_detail": null
        }
      },
      "mechanism": "antimicrobial action and growth factor stimulation",
      "mechanism_canonical_names": [
        "Antimicrobial action and growth factor stimulation"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 2631,
        "duration": null,
        "population": "patients with diabetic foot ulcers",
        "adverse_effects": "no serious adverse events",
        "cost_category": null,
        "study_focus": [
          "efficacy and safety of wound dressings",
          "comparison of healing time and efficiency"
        ],
        "measured_metrics": [
          "wound healing time",
          "healing efficiency",
          "adverse events"
        ],
        "findings": [
          "novel biomaterials and antimicrobial dressings combined with growth factors significantly shortened wound healing time",
          "epidermal growth factor-based regimens showed higher healing efficiency than traditional dressings",
          "silver ion dressings combined with basic fibroblast growth factor ranked highest for wound healing time",
          "honey dressings showed favorable results in sensitivity analyses for ulcer healing time",
          "no serious adverse events reported across interventions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Efficacy and Safety of Biomaterials and Antimicrobial Dressings in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Network Meta-Analysis.",
        "journal": "Journal of diabetes research",
        "publication_date": "2025",
        "pubmed_id": "41103345",
        "doi": "10.1155/jdr/1548984"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:45:28"
    },
    {
      "id": 79,
      "intervention": {
        "name": "epidermal growth factor-based regimens with hydrogel",
        "canonical_name": "epidermal_growth_factor_based_regimens_with_hydrogel",
        "category": null,
        "categories": {
          "primary": [
            "growth_factor_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "growth_factor_therapy",
          "layer_1_canonical": "epidermal_growth_factor_based_regimens_with_hydrogel",
          "layer_2_variant": "epidermal growth factor-based regimens with hydrogel",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic foot ulcers",
        "canonical_name": "diabetic foot ulcers",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "diabetic foot ulcers",
          "layer_2_variant": "diabetic foot ulcers",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhanced epithelialization and wound closure",
      "mechanism_canonical_names": [
        "Enhanced epithelialization and wound closure"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 2631,
        "duration": null,
        "population": "patients with diabetic foot ulcers",
        "adverse_effects": "no serious adverse events",
        "cost_category": null,
        "study_focus": [
          "efficacy and safety of wound dressings",
          "comparison of healing time and efficiency"
        ],
        "measured_metrics": [
          "wound healing time",
          "healing efficiency",
          "adverse events"
        ],
        "findings": [
          "novel biomaterials and antimicrobial dressings combined with growth factors significantly shortened wound healing time",
          "epidermal growth factor-based regimens showed higher healing efficiency than traditional dressings",
          "silver ion dressings combined with basic fibroblast growth factor ranked highest for wound healing time",
          "honey dressings showed favorable results in sensitivity analyses for ulcer healing time",
          "no serious adverse events reported across interventions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Efficacy and Safety of Biomaterials and Antimicrobial Dressings in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Network Meta-Analysis.",
        "journal": "Journal of diabetes research",
        "publication_date": "2025",
        "pubmed_id": "41103345",
        "doi": "10.1155/jdr/1548984"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:45:28"
    },
    {
      "id": 80,
      "intervention": {
        "name": "platelet-rich plasma with hydrogel",
        "canonical_name": "platelet_rich_plasma_injection",
        "category": null,
        "categories": {
          "primary": [
            "regenerative_medicine"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "regenerative_medicine",
          "layer_1_canonical": "platelet_rich_plasma_injection",
          "layer_2_variant": "platelet-rich plasma with hydrogel",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic foot ulcers",
        "canonical_name": "diabetic foot ulcers",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "diabetic foot ulcers",
          "layer_2_variant": "diabetic foot ulcers",
          "layer_3_detail": null
        }
      },
      "mechanism": "release of growth factors and anti-inflammatory effects",
      "mechanism_canonical_names": [
        "growth factor release and anti-inflammatory effects"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 2631,
        "duration": null,
        "population": "patients with diabetic foot ulcers",
        "adverse_effects": "no serious adverse events",
        "cost_category": null,
        "study_focus": [
          "efficacy and safety of wound dressings",
          "comparison of healing time and efficiency"
        ],
        "measured_metrics": [
          "wound healing time",
          "healing efficiency",
          "adverse events"
        ],
        "findings": [
          "novel biomaterials and antimicrobial dressings combined with growth factors significantly shortened wound healing time",
          "epidermal growth factor-based regimens showed higher healing efficiency than traditional dressings",
          "silver ion dressings combined with basic fibroblast growth factor ranked highest for wound healing time",
          "honey dressings showed favorable results in sensitivity analyses for ulcer healing time",
          "no serious adverse events reported across interventions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Efficacy and Safety of Biomaterials and Antimicrobial Dressings in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Network Meta-Analysis.",
        "journal": "Journal of diabetes research",
        "publication_date": "2025",
        "pubmed_id": "41103345",
        "doi": "10.1155/jdr/1548984"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:45:28"
    },
    {
      "id": 81,
      "intervention": {
        "name": "honey dressings",
        "canonical_name": "honey_dressings",
        "category": null,
        "categories": {
          "primary": [
            "topical_therapy"
          ]
        },
        "details": "{}",
        "delivery_method": "topical",
        "hierarchy": {
          "layer_0_category": "topical_therapy",
          "layer_1_canonical": "honey_dressings",
          "layer_2_variant": "honey dressings",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "diabetic foot ulcers",
        "canonical_name": "diabetic foot ulcers",
        "category": null,
        "categories": {
          "primary": [
            "endocrine"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "endocrine",
          "layer_1_canonical": "diabetic foot ulcers",
          "layer_2_variant": "diabetic foot ulcers",
          "layer_3_detail": null
        }
      },
      "mechanism": "antimicrobial properties and moisture retention",
      "mechanism_canonical_names": [
        "Antimicrobial properties and moisture retention"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "systematic review and network meta-analysis",
        "sample_size": 2631,
        "duration": null,
        "population": "patients with diabetic foot ulcers",
        "adverse_effects": "no serious adverse events",
        "cost_category": null,
        "study_focus": [
          "efficacy and safety of wound dressings",
          "comparison of healing time and efficiency"
        ],
        "measured_metrics": [
          "wound healing time",
          "healing efficiency",
          "adverse events"
        ],
        "findings": [
          "novel biomaterials and antimicrobial dressings combined with growth factors significantly shortened wound healing time",
          "epidermal growth factor-based regimens showed higher healing efficiency than traditional dressings",
          "silver ion dressings combined with basic fibroblast growth factor ranked highest for wound healing time",
          "honey dressings showed favorable results in sensitivity analyses for ulcer healing time",
          "no serious adverse events reported across interventions"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Efficacy and Safety of Biomaterials and Antimicrobial Dressings in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Network Meta-Analysis.",
        "journal": "Journal of diabetes research",
        "publication_date": "2025",
        "pubmed_id": "41103345",
        "doi": "10.1155/jdr/1548984"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:45:28"
    },
    {
      "id": 82,
      "intervention": {
        "name": "Unified Protocol (UP) psychotherapy",
        "canonical_name": "unified_protocol_psychotherapy",
        "category": null,
        "categories": {
          "primary": [
            "psychotherapy"
          ]
        },
        "details": "{}",
        "delivery_method": "behavioral",
        "hierarchy": {
          "layer_0_category": "psychotherapy",
          "layer_1_canonical": "unified_protocol_psychotherapy",
          "layer_2_variant": "Unified Protocol (UP) psychotherapy",
          "layer_3_detail": null
        }
      },
      "condition": {
        "name": "depressive and anxiety disorders",
        "canonical_name": "depressive and anxiety disorders, major depressive disorder",
        "category": null,
        "categories": {
          "primary": [
            "psychiatric"
          ]
        },
        "severity": null,
        "hierarchy": {
          "layer_0_category": "psychiatric",
          "layer_1_canonical": "depressive and anxiety disorders, major depressive disorder",
          "layer_2_variant": "depressive and anxiety disorders",
          "layer_3_detail": null
        }
      },
      "mechanism": "enhances self-awareness alignment with personal values",
      "mechanism_canonical_names": [
        "cognitive-behavioral alignment"
      ],
      "correlation": {
        "type": "improves",
        "study_confidence": null
      },
      "bayesian_scoring": null,
      "study": {
        "type": "randomized controlled trial (secondary analysis)",
        "sample_size": 104,
        "duration": null,
        "population": "patients with depressive (n=52) and anxiety disorders (n=52)",
        "adverse_effects": null,
        "cost_category": null,
        "study_focus": [
          "mediating role of authenticity in psychotherapy",
          "effectiveness of UP on authenticity"
        ],
        "measured_metrics": [
          "Sense of Authenticity Scale scores",
          "depression symptom severity",
          "therapeutic alliance"
        ],
        "findings": [
          "UP group showed 0.97 higher authenticity (d=0.97, 95% CI [0.28, 1.65]) vs controls at post-treatment",
          "authenticity mediated 22.90% of UP's effect on depression (b=-6.51, 95% CI [-14.04, -1.88])",
          "effect sustained at 6-month follow-up"
        ],
        "study_location": null,
        "publisher": null
      },
      "paper": {
        "title": "Authenticity as a Mediator of Change in the Unified Protocol for Transdiagnostic Treatment of Depressive and Anxiety Disorders.",
        "journal": "Clinical psychology & psychotherapy",
        "publication_date": "2025",
        "pubmed_id": "41090958",
        "doi": "10.1002/cpp.70161"
      },
      "supporting_quote": null,
      "extraction_model": "qwen3:14b",
      "extraction_timestamp": "2025-10-17 22:58:42"
    }
  ]
}